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ABSTRACT

Analysis of cell signaling perturbations in response to chronic localized
infections
Nicole Prince
The tissue-level response to pathogens involves an intricate series of signal transduction
events, influenced by immune and healing mediators that alert the host to danger and eliminate the
infection. Disruptions to normal signaling events can compromise the host’s ability to respond and
lead to the development of chronic infections that cannot be resolved without clinical intervention.
Prolonged inflammation due to chronic infection can damage tissues and compromise healing
processes, thus, the interactions of immune and healing mediators in signaling cascades are
intimately linked to tissue health outcomes. Studying signaling networks relevant to these
responses provided a more thorough understanding of localized tissue health to identify the drivers
of disruptions to signaling cascades, and this knowledge can lead to the development of improved
diagnostic and therapeutic biomarkers to combat chronic infections. The work presented here
focused on elucidating the relationships between immune and wound healing factors in an in vivo
rodent model and a clinical cohort to understand the tissue-level responses to chronic inflammation
and infection. Specifically, extracellular inflammatory immune responses (i.e., cytokines and
chemokines) related to intracellular signaling (i.e., phosphorylation of proteins) were investigated
to identify alterations in native responses compared to those provoked by chronic inflammation
and infection. Reponses in native tissues were compared to tissues with inflammatory and
infectious stimuli to test if levels of immune related cytokines were elevated in response to chronic
joint infections. Wound healing phosphoproteins were also included to look for shifts in wound
healing-related processes across groups. Traditional statistical approaches and network analysis
were used to dissect these complex biological datasets and identified drivers of network disruptions
in response to inflammation and infection. The spatial analysis suggested that changes in biological
responses were related to proximity to inflammation and infection, and the degree of response
differed across spatial gradients, which demonstrated the ability for these chronic insults to affect
disparate tissues in a clinically-relevant manner. The objective of this research and future related
research is to facilitate new clinical strategies to combat chronic infection, and monitoring
alterations to cell signaling pathways in this work highlighted the value of using network analysis
to approach biological interrogation of signal disruptions related to these insults.
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Chapter 1
Introduction to cellular signaling networks of infection and strategies for
analysis

1

Overview of biological cell signaling
1.1.1 Components of biological cell signaling
Cells respond to cues from their environments through relays of complex signaling
networks, creating a path for adaptation towards survival, proliferation, or death. Understanding
these signal transduction networks is crucial when studying complex biological responses, such as
those observed in chronic inflammation and infection. Cell signaling was first observed in
hormonal studies by Claude Bernard in 1855, who described that hormones released into the
bloodstream produced effects in distant cells [1]. Bernard created a new concept of the “milieu
intérieur” which described regulation through complex cellular feedback signaling to maintain
homeostasis. Specifically, he described how interstitial fluid in the extracellular environment can
provide a protective barrier for cells and tissues to preserve stability in response to stimuli. Since
then, biological signaling has been pursued by a wide variety of biochemical researchers, and the
term “signal transduction” as it is known now was first coined in the 1970s, providing the basis
for the modern model of cell signaling, consisting of receptors, transducers, and amplifiers [2].
When a signal ligand binds to a receptor, this information is transduced into the intracellular space
and amplified within the cell to produce a response, and examples of signal ligands include growth
factors, hormones, cytokines, neurotransmitters, and many other small molecules. The release of
these signals can reflect perturbations to the homeostatic state, and signal transduction is the
primary means for communicating this information within and between cells. A simplified diagram
of the incorporation of external stimuli to produce cell signaling changes in cells is shown in
Figure 1.1.
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Figure 1. 1. Cellular Response to External Stimuli. When a change occurs in the external
environment, cells respond to this input through receptors. Sensors convert this to communicate
signals that are meaningful to the organism. A controller compares this signal to a desired “set
point” of the homeostatic state to alert the cell if there is a discrepancy. Activators interact with
effectos to initiate a response, and this feedback communicates to the original receptor whether or
not homeostasis has been achieved. This phenomenon describes how external cues to initiate
changes within the cell.

Signal transduction provides instructions for the cell relevant to cell communication, cell
cycle control, pathogen sensing, neurotransmission, and many other biological processes that
affect target cells within the organism through the initiation of one of four modes of signaling:
autocrine signaling, direct signaling, paracrine signaling, and endocrine signaling [3]. Autocrine
signaling is a self-activation in which a ligand acts on the same cell that released it, as shown in
Figure 1.2.a. Direct cell signaling, as the name suggests, involves direct communication between
cells in contact with one another and is often mediated by gap junctions, which are clusters of
intercellular channels that allow direct transfer of small molecules and ions. This type of signaling
is alternatively referred to as juxtacrine signaling (Fig. 1.2.b). Signaling can also occur between
neighboring cells not in direct contact via paracrine signaling. In paracrine signaling, signal ligands
diffuse a short distance through the extracellular space to activate the target cell (Fig. 1.2.c). Finally,
3

signaling can occur between distant cells. Endocrine signaling is achieved through secreted
molecules that travel through the bloodstream to activate target cells that are further away from
the signaling cell. This type of signaling is often utilized by hormones (Fig. 1.2.d).

Figure 1. 2. Modes of cellular signal transduction. Signals can be transmitted through four primary
mechanisms: (a) autocrine signaling, in which a ligand activates a receptor on the same cell that
released it; (b) direct signaling between two cells in contact with one another; (c) paracrine
signaling, in which the ligand travels a short distance to bind to a receptor on a target cell; and (d)
endocrine signaling occurs when ligands travel through the bloodstream to activate target cells.

Signaling networks can produce immune-related responses through any of these four
mechanisms, and sometimes the multiple mechanisms can be employed by the same molecule.
Cytokines represent a diverse group of immune-related molecules that participate in these
signaling pathways to transmit intracellular and intercellular signals and are an integral part of
inflammation and the response to pathogens. The term “cytokine” represents a broad group of

4

chemokines, interferons, interleukins, lymphokines, and tumor necrosis factors that play critical
roles in cell communication. They typically achieve this through autocrine (Fig. 1.2a) and
paracrine (Fig 1.2c) signaling but can simultaneously use multiple signaling mechanisms.
Cytokines are often associated with localized signaling to alert and recruit immune cells [4], but
many cytokines have illustrated communication via long-range endocrine signaling (Fig. 1.2.d),
such as interleukin(IL)-1 transport through the bloodstream to alert distant cells to the presence of
pathogens [5].

Once an initiating signal has been produced through any of these mechanisms, it can bind
to cell surface receptors. Cell surface receptors traverse the plasma membrane and have specific
signal binding domains in the extracellular space, converting external stimuli into an intracellular
signal. Upon binding, there is a conformational change to activate the receptor’s cytoplasmic
domain, often provoking enzyme activity from kinases, phosphatases, and adaptor molecules [6].
Intracellular receptors are present on the nucleus, cytosol, mitochondria, endoplasmic reticulum,
and Golgi apparatus and serve to propagate and amplify the signaling events initiated through this
extracellular binding. Intracellular binding targets widely vary and frequently affect transcription
and gene expression [3], illustrating the connection between external stimuli and intracellular
signal transduction pathways, such as activation of the mitogen-activated protein
kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway and the Janus kinase/signal
transducers and activators of transcription (JAK/STAT) pathway. Extracellular signals (e.g.,
cytokines) produced in response to stressors, like inflammation and infection, ultimately affect the
intracellular pathways that dictate growth, proliferation, survival, and cell death [7].

5

External cues can produce various effects in cells, highlighting the importance of
specificity in these signal transduction cascades. Specificity in cell signaling events is a hallmark
of ligand binding and allows the cell to be highly adaptive while also producing diverse responses,
and this specificity is achieved in two ways. First, receptors exhibit a high affinity for ligands,
resulting in specificity of the ligand binding interaction. Receptor specificity depends on the
ligand’s binding affinity and binding domains, so these specific ligand interactions ultimately
dictate the biological effect. Specificity in cytokine binding to members of the JAK/STAT family
allows for diverse bioactivity, as is the case with the IL-6 versus IL-10. While both cytokines
activate STAT3, IL-6 produces pro-inflammatory effects while IL-10 has an anti-inflammatory
role [8]. Another mechanism to achieve specificity in cells is the varied expression of types and
proportions of receptors, both inside and outside the cell. Therefore, cell types can be specialized
for specific functions depending on the receptors expressed. Immune-related cells express specific
and distinct cell surface receptors critical for the host response to pathogens. Antigen-presenting
cells (APCs) are essential in the early response to pathogens, and they respond to environmental
stimuli through toll-like receptors (TLRs) for pathogen identification [9]. Receptor expression
allows diversity of signaling events related to cell type.

Signal transduction networks in the immune response to infection involve an
extraordinarily complex system of cascades, and actions of these signaling mediators have
consequences for cellular fate. The binding of extracellular signals affects intracellular signaling
and produces bioactivity that directs the cell towards survival or death. Specificity of cell signaling
is crucial because it allows cells to perceive a wide range of stimuli while maintaining strictly

6

regulated biological outputs. Ultimately, these tightly regulated networks enable external cues and
stressors to determine cell fate.

1.1.2 Interactions of cell signaling pathways
While specific ligand-receptor interactions and varied receptor expression allow for a high
degree of specificity, interactions between signaling pathways add another layer of complexity,
involving mutual influences of signals originating from disparate pathways. Following the initial
signal relay through receptor binding, activation of small molecule second messengers like cAMP,
calcium, and DAG can promote second messenger interactions with other pathways. The extent of
pathway interactions during immune and inflammatory responses is unknown, but evidence
suggests it occurs between different inflammatory cell types, immune-related cytokines, and in
intracellular signaling pathways like MAPK/ERK and JAK/STAT [10]. Overlap and integration
of cell signaling pathways primarily occur in three different ways: (1) multiple inputs that converge
to produce a response, (2) signal gating, in which a signal output from one pathway is regulated
by a second pathway, and (3) the establishment of feedback loops. All three of these regulating
mechanisms have been observed in signaling networks related to the immune response to infection.
These types of interactions between cell signaling pathways highlight the functional specificity of
signaling mediators, a term to describe how structurally similar proteins can produce distinct
outcomes, introducing more diversity in response.

Coincidence detection is the convergence of two cellular pathways to produce one output;
the important distinction from single pathway signaling is that both inputs must be present to elicit
a response, and the combined response is different than the individual products of each activation
7

(Figure 1.3a). T cell survival is dependent on T cell antigen receptor signaling convergence with
IL-2 and IL-7 cytokine activation, and, without the presence of IL-2 or IL-7, pro-apoptotic proteins
FasL and Bim are up-regulated, leading to apoptosis of T cells [11]. Coincidence detection of these
cytokines in conjunction with T cell antigen receptor signals is critical for T cell survival. Many
other examples exist in complex, highly conserved signaling pathways related to immunity, and
these add diversity to the roles of signaling molecules. In response to different cytokines,
JAK/STAT pathways can be activated in immune cells to produce distinct, cell-type-specific
responses [12]. While many of these signaling events are not well defined, the dependence on
multiple pathway convergence does enlighten the diversity of cell signaling outputs.

Gating is another common form of pathway interaction in which one signaling pathway
evokes a response and is modulated by a second pathway, resulting in either activation or inhibition
of the first pathway (Fig. 1.3b). An important feature of regulation via gating is that one signaling
pathway can regulate the flow of another pathway, thus stimulating or prohibiting its response [13].
The GTP binding protein Ras influences the ERK proliferative response through this mechanism
via the second messenger cAMP. When cAMP levels increase, protein kinase A (PKA) is activated,
which subsequently phosphorylates and deactivates Raf, leading to decreased ERK stimulation
and reduced proliferation [14]. The gating mechanism creates a complex web of regulation to
connect related cellular processes, ultimately allowing extracellular ligand action from one
pathway to dictate intracellular actions related to growth and proliferation.

8

Feedback loops establish a direct relationship between cellular outputs and the initial input,
and they are influential in signaling networks in homeostasis [15], metabolism [16], transcriptional
regulation [17], and immune response to infection [18]. Negative feedback loops are a hallmark of
almost all known signaling pathways, attenuating the allowed output through positive or negative
feedback. The output signal is produced and converted before being fed back into the input, and
this new input can subsequently activate or deactivate the initial pathway (Fig. 1.3c). This type of
feedback is necessary for adaptation to the extracellular environment, as eukaryotic cell machinery
is built to respond to changes, and cytokine-mediated inflammation employs feedback loops to
regulate the degree of inflammation in response to infection or insult. In response to pathogens,
IL-1β is released as an early initiator of infection, and subsequent IL-1β signaling elevates levels
of its receptor, IL-1Ra, which- in turn- negatively regulates the production of IL-1β and allows a
controlled reduction of the immune response [10]. In this way, the cells respond adaptively to
changes in their environment rather than solely relying on absolute amounts of a particular signal.
Positive feedback occurs when the output is fed back into the input unchanged, thereby amplifying
the signal, and this feedforward regulation is also common in immune signaling [19]. In complex
networks, signaling pathways can have multiple feedback loops and mixed loops, which contain
both positive and negative components.

9

Interactions of cell signaling pathways add complexity and allow more variety in biological
outputs. Coincidence detection, gating, and feedback loops illustrate three mechanisms by which
cells can diversify the responses based on the presence of two or more signaling molecules, which
may partially explain the benefit of the pleiotropic and redundant nature of signaling molecules
(e.g., cytokines) and how this relates to functional specificity [8]. Gaining insights into the
interactions of disparate immune-related signaling pathways will certainly enlighten
understanding of the correlations between immune signals and responses when multiple cytokines
and immune-related mediators are involved.

A

C

B

Figure 1. 3. Interactions of Cell Signaling Pathways. Overlap of cell signaling pathways can
produce a response in different ways. A) Coincidental detection involves two signals converging
to produce one response. B) Gating is a mechanism in which one signal pathway (Signal A) can
stimulate or inhibit another pathway (Signal B). C) Feedback loops allow a signal (Signal C) to
activate a pathway (Signal A) while also providing regulation of that pathway (Signal B).

1.1.3 Protein phosphorylation in cell signaling
Post-translational modifications (PTMs) are a frequently observed mechanism for
regulating protein activity in cell signaling cascades, primarily via small covalent changes to their
chemical structures (Figure 1.4). PTMs add diversity to the proteome and can modify protein
activity through the addition of complex molecules, peptides, chemical groups, and cleavage of
10

functional subunits [20]. The addition of these groups often acts as an on/off switch for protein
activity, and PTMs serve as regulatory mechanisms for many signal transduction pathways, often
through previously-discussed regulatory mechanisms like feedback loops (Fig. 1.3). Protein
modifications can also regulate activity via gating by inducing conformational changes that lead
to active or inactive states, which can promote or inhibit binding to receptors.

Figure 1. 4. Mechanism of phosphorylation and dephosphorylation. Kinases perform a hydrolysis
reaction to covalently attach a phosphate group from ATP to a protein at polar R groups of amino
acids. ATP coordination with Mg2+ (shown in green) is essential for the transfer of a phosphate
group. Phosphorylated proteins can be dephosphorylated by phosphatases, which hydrolyze the
phosphoric acid monoesters, which results in ADP converting back to ATP. A free hydroxyl group
remains on the protein after removal of the phosphate group. Reproduced with permission from
John Wiley & Sons, Inc.
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Protein phosphorylation was one of the first PTMs identified, and it has a role of regulation
in key biological processes through simple biding of a phosphate group. In 1956, Krebs and Fischer
demonstrated that reversible phosphorylation controlled glucose storage [21]. Through kinase
activity, phosphate groups are added to polar R groups of serine, threonine, or tyrosine residues.
The addition of a PO4 group causes a conformational change, which can aid or prevent proteinprotein interactions. Phosphorylation is negatively regulated by phosphatase enzymes, which can
remove the phosphate group, and the mechanism of phosphorylation/dephosphorylation is
illustrated in Figure 1.4 [22]. These processes influence energy availability, making
phosphorylation an especially important PTM in cellular signaling. Energy availability is
predictive of cellular fate, and this can be experimentally observed by monitoring protein
phosphorylation as a marker of mitochondrially-driven kinase activity [23]. Phosphorylation has
been studied in bacterial and mammalian systems and has demonstrated a role in a broad range of
cellular processes, such as membrane transport, protein degradation, and enzyme regulation. The
biological implications of these activities are important in bioenergetics, cell proliferation, and the
development of disease states. Monitoring phosphorylation events, especially concerning immune
signaling, has proven useful in understanding the disrupted cell signaling events that can delay
healing [24].

Historically, cell signaling research has focused on distinct pieces of signaling cascades to
understand specific regulators, but spatial and temporal regulation of these signals, including
PTMs, is an increasingly compelling problem to study in the field of biochemistry. New
developments in multi-‘omics technologies have made the investigation of a large number of
related targets more accessible than ever before. Recent research efforts have focused on
12

understanding not only the individual components of cell signaling pathways, but they have also
expanded to investigate interactions between pathways. Many researchers have begun to approach
this problem by studying signaling pathways as a whole to understand the influence of individual
components and their respective relationships. Future research can continue to understand how
these complex signaling pathways interact to produce diverse biological consequences.

The immune response to infection
1.2.1 Acute immune response
The mammalian immune system serves to protect the host from harmful pathogens, and
this response involves the coordination of multiple cell signaling pathways, including cytokine
immune mediation [25], MAPK/ERK activation [26], and JAK/STAT signaling [27]. The immune
system’s primary function is to eliminate pathogenic microbes if they breach the mucosal barrier,
and both innate and adaptive immune strategies are utilized to identify and target harmful
pathogens via pathogen recognition receptors (PRRs). PRRs recognize specific structures of
pathogens known as pathogen-associated molecular patterns (PAMPs), and this initiates a cascade
to eliminate the pathogen [28]. The acute immune response is the initial attempt to combat the
infection. Cytokines are essential mediators of this response, acting as communicators to recruit
immune cells and resolve infection through short-range autocrine signaling and paracrine signaling
[4, 5], and long-range endocrine signaling [29]. Cytokines are produced by immune-specific cells
such as B lymphocytes, T lymphocytes, macrophages, and mast cells [30], or by endothelial cells,
fibroblasts, and stromal cells [31], which are all capable of releasing cytokines as an “alert” to the
localized environment. Murine models have established that this acute response period commences
at pathogen recognition and can persist to approximately 21 days post-infection [32]. The initial
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inflammatory response activates NF-κB and MAPK pathways, resulting in the production of
cytokines IL-1α, IL-1β, TNF-α, IL-2, and IL-18 [33]. These cytokines regulate the activities of Thelper cells, macrophages, and neutrophils to control immune cell differentiation and maturation
[34], interact with growth factors that control angiogenesis [35], and influence cellular fate by
activation of NF-κB signaling to regulate apoptosis [33]. Extracellular cytokines bind to receptors
to propagate these intracellular signaling cascades, impacting the transcription of proteins central
to these cellular processes. Cytokines like IL-6, IL-10, IL-12, IL-4, IL-13, and IFN-α/β activate
STAT proteins, activating TH1-related responses to propagate immune cell activity [27]. The
effects of early cytokine activity produce a robust inflammatory response that is beneficial for
resolving pathogens, but it is somewhat unregulated.

The potent inflammatory response elicited early on by cytokines can combat bacterial
invasion, but it can also result in tissue damage if left unregulated. The initial cytokine response
functions much like a sensor of infection, followed by a more targeted approach adopted by the
immune system following this uncontrolled release of cytokines, with careful control of activity
through gating, feedback mechanisms, and signaling crosstalk. The downstream activity of
cytokine activation through receptor binding often serves as a negative regulator of cytokine
activity [10], so cells can adapt following the initial cytokine surge. Sophisticated communication
between multiple cell signaling pathways, including MAPK/ERK, NF-κB, and JAK/STAT
signaling [29] to balance the activity of pro-inflammatory and anti-inflammatory cytokines
facilitate this adaptation to resolve infection most efficiently. The cytokine response to infection
persists until the infection has been eliminated from the host. Balancing the initial inflammatory
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response and activation of effectors achieves pathogen resolution without producing harmful
effects in surrounding tissues.

1.2.2 Chronic infections and immune response
When the acute response to infection cannot resolve or fully eliminate the pathogen, the
infection can transition into a chronic state, and both environmental and biological factors can
contribute to this outcome. The causes for failure of acute response are not fully understood, but
several risk factors have been identified, including autoimmune disease, obesity, and age [36].
During infection, a critical balance must be struck by immune mediators to prevent tissue damage,
but chronic infections result in persistent activation of inflammation until immune cells become
exhausted [37], causing a variety of consequences for cell signaling. In chronic bacterial infections,
disrupted immune responses are marked by continuous stimulation of Th1/Th17 lymphocyte proinflammatory mediators and a failure of Th2 anti-inflammatory mediators [38]. Reduction of antiinflammatory influence causes the signaling networks to be shifted towards excessive cell death,
which disrupts immune cells’ ability to resolve the infection and damages the surrounding tissue,
thereby perpetuating the infection. Network analysis of chronic infection states has revealed
distinct shifts away from growth, proliferative, and immune differentiation metabolic activities
hallmark of the acute response towards heavy metabolic activity with increased progression
towards apoptosis and programmed cell death [39].

Errant cell signaling has also been attributed to failures in signal transduction regulatory
loops. In chronic infections, the deactivation of crucial downstream regulators of cytokine activity
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has been observed, such as dephosphorylation in c-Jun, p38, and ERK1/2 [40]. Phosphorylation
of these proteins typically serve as negative regulators of inflammatory cytokine activity, but this
represents one example of disrupted cell signaling cascades in chronic infection states. While this
has not been explicitly linked to the disrupted cytokine activity and reduced anti-inflammatory
capacity, it introduces a potential explanation for how a shift in the cytokine pro- and antiinflammatory balance may eventually stimulate increased cell death [41]. The reduced capacity of
immune cells observed in persistent infection suggests that these signaling disruptions overwhelm
host immunity, causing an inability to resolve the infection. Disruptions to signaling networks can
be influenced by infection duration, infecting organism, and tissue type.

1.2.3 Bacterial hijacking of host cell signaling
While the mechanisms of disrupted cell signaling in infection are not entirely understood,
microbial agents have demonstrated the ability to hijack host cell signaling machinery to decrease
the efficacy of host defense strategies, and some of these effects play a role in the transition to
chronic infection. One way bacteria affect host immune response is by producing toxins that
corrupt cell signaling cascades and dampen the effects of mediators critical for the early
recognition of pathogens [42]. Without this initial alert and warning to the host immune system,
pathogens can go undetected, ultimately disrupting the normal sequence of pathogen clearance via
immune signaling [43]. The VacA cytotoxin of H. pylori has been shown to delete genes in host
immune cells vital to inflammatory response, blocking several early pro-inflammatory cytokines
involved in early infection response like IL-6 and IL-8 [44]. Similarly, M. tuberculosis subverts
macrophages to downregulate TNF-α, IL-12, and IL-1β and shut down pro-inflammatory
responses [45]. Bacteria like Yersinia ssp., Shigella ssp., and E. coli produce other peptides or
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small molecules that can interfere with cell signaling cascades by inhibiting critical signaling
mediators and coopt entire signaling systems, resulting in a decreased ability for pathogen
recognition [46]. These bacteria cause deleterious effects through the exploitation of host signaling.

Bacterial hijacking of cell machinery has been observed for many pathogens, and the exact
mechanisms of disruption vary depending on infecting organism and the extracellular environment.
The presence of non-infectious inflammatory stimuli, such as those associated with obesity or
chronic inflammatory conditions, can influence how bacteria interact with host cell signaling
pathways. The unique environment created by inflammatory disease coupled to infection is more
complex than bacterial invasion alone because the cascades initiated by recognition of PAMPs
often overlap with those triggered by damage-associated molecular patterns (DAMPs) from noninfectious stimuli. Both PAMPs and DAMPs cause persistent activation of pro-inflammatory
mediators through activation of NF-κB and p38 MAPK pathways [47], so the overlap of chronic
inflammatory disease and infection may not have the same effect as the sum of the individual
insults. The intersection of chronic inflammatory conditions and subsequent infection is not well
studied, but obesity and rheumatoid arthritis are two conditions that are frequently plagued by
concurrent infection. Obesity impairs the immune response to infection by promoting T cell
senescence, which affects the production of early pro-inflammatory cytokines [48]. Although the
mechanistic effects have not been explicitly studied, increased incidence of chronic infection in
obese patients compared to non-obese individuals suggest the suppressive effects on cell signaling
may be advantageous for bacterial interference with signaling cascades. Rheumatoid arthritis is
another disease that alters immune-related cell signaling and has been associated with an increased
risk of chronic infection. Several cytokines, like 1L-1α, IL-1β, and TNF-α, are up-regulated in
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arthritis, and chronic activation of these pro-inflammatory mediators can cause damage to bone
and cartilage [49]. Damaged tissue creates an ideal environment for infection, so the compromised
tissue combined with immunomodulatory effects of the disease may create an environment that is
conducive to bacterial disruption of immune function. Altered immune signaling when both
infectious and non-infectious sources are present continues to be an intriguing problem, and the
rising prevalence of chronic inflammatory conditions like obesity and rheumatoid arthritis in the
United States makes them an extremely relevant problem to study [50].

Disruptions to cell signaling pathways observed in pathological conditions
1.3.1 Periprosthetic joint infection (PJI) and immune signaling
Elucidating changes in cell signaling networks provoked by chronic infection may provide
a better understanding of the drivers of dysregulation in a range of clinical pathologies. One
example of a chronic infection is periprosthetic joint infection (PJI), a devastating post-operative
complication following total knee arthroplasty (TKA) and total knee revision (TKR) procedures,
and these infections have high clinical relevance for the field of Orthopaedics. Over one million
joint revision procedures are conducted in the United States every year, and the popularity of TKA
procedures is projected to grow rapidly [51]. While joint replacement is a life-enhancing procedure
for many people, infections can develop and affect both the joint prosthesis and surrounding tissues.
PJIs occur in approximately 2% of joint revisions and affect tens of thousands of patients per year,
imposing high emotional and financial burdens on these individuals [52, 53]. They can be caused
by a variety of bacteria, but Staphylococcus aureus is the most common pathogen implicated [54].
Many PJIs become chronic due to bacteria’s ability to evade host response by forming protective
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biofilm barriers and interference with host immune efforts [55], and changes in cytokine and
immune signaling pathways have been observed.

The localized PJI environment is affected both by inflammation due to foreign body
implants and the modulatory effects of the bacteria. Surrounding tissues often exhibit elevated
levels of localized cytokines due to prosthesis alone [56], and the presence of S. aureus can have
additional effects on host adaptive immunity. PJIs due to S. aureus have been shown to dampen
leukocyte activity and reduce phagocytosis following bacterial invasion. S. aureus also employs
countermeasures, including provocation of anti-inflammatory mediators, to combat the robust proinflammatory response of surrounding tissues [57], similar to previously discussed bacterial
hijacking strategies to target early pathogen recognition. The prevailing theory of why PJIs become
chronic and difficult to treat is the devastation to the localized environment overcomes the immune
system’s ability to combat the infection, so it is critical to dissect the specific influences of PJIs on
surrounding tissues. The effects of chronic PJI on localized tissues have recently become of interest
for researchers in the field of Orthopaedics [58-60].

Studying the specific deviations in immune signaling could lead to the identification of
tissue-level biomarkers of PJI relevant to treatment. Once chronic PJI is established, it is difficult
to treat, but surgical strategies can manage the infection. The gold standard involves debridement
and irrigation of the wound area to remove infected tissues, either decreasing the bacterial load to
a level the immune system can overcome or completely removing the infected tissues. While this
strategy shows the highest rates of success in persistent PJI, it is expensive and often requires
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additional surgical intervention [52]. Further, debridement is a subjective technique in which the
surgeon is tasked with visually inspecting the tissue to determine viability. While Orthopaedic
surgeons undergo extensive training, it can be challenging to eradicate infected tissue using only
visual inspection. Even a small number of bacteria remaining (i.e., a few colonies) can lead to reinfection of the joint [61]. Failure rates of procedures can reach as high as 50% in infected joints,
partly because subjective measures of debridement are not sufficient [62]. Delineating healthy and
infected tissues in PJI is critical, but no tissue-level biomarkers are established for intra-operative
assessment to inform treatment.

Several biomarkers have been identified for their diagnostic utility in PJI but have not been
investigated for their ability to identify healthy versus infected tissues. While serum and synovial
fluid measurements of cytokines like IL-1β, IL-6, IL-10, and IL-8 have been incorporated into
clinical protocols for PJI diagnosis [63], they do not provide information about tissue viability.
Establishing diagnostic biomarkers of infected tissues in PJI requires a high degree of sensitivity
and specificity [64]. Sensitivity is a measure of how well the biomarker identifies true positives
(e.g., how many tissues are correctly identified as infected; Equation 1.1). Low sensitivity can lead
to a high number of false negatives, or type II error. Specificity describes how well the biomarker
determines true negatives (e.g., how many healthy tissues can be identified as non-infected;
Equation 1.2). Low specificity can lead to a high number of false positives, or type I error. In
biomarker development, there is a balance between sensitivity and specificity, with higher
sensitivity leading to lower specificity and vice versa.
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𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 =

𝑇𝑟𝑢𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠
𝑇𝑟𝑢𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠 + 𝐹𝑎𝑙𝑠𝑒 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠

(1.1)

𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 =

𝑇𝑟𝑢𝑒 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠
𝑇𝑟𝑢𝑒 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠 + 𝐹𝑎𝑙𝑠𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠

(1.2)

Biomarker analysis through enzyme-linked immunosorbent assays (ELISAs) is an
attractive analytical technique to investigate targets related to tissue health in PJI. Due to the
complexity of the inflammatory environment, it would likely be advantageous to study a suite of
immune-related targets and the healing cascades associated with tissue damage in chronic infection
and inflammation. Many immune and healing mediators exhibit low homeostatic concentrations
in blood or localized fluids (e.g., picomolar) [65, 66], but stimulation by inflammatory stressors
like infection can cause increases of up to 1,000-fold [67]. Cost-effective, high throughput
multiplexed ELISAs offer a solution to investigate multiple targets related to immune and healing
processes simultaneously. Multiplexed assays use multiple antibodies immobilized to the surface
of a polystyrene bead, and measurements are made using a dual-laser flow cytometric system [68].
Multiple detection antibodies are used, and dyes correspond to the analyte of interest, and up to
100 different antibody-antigen combinations can be included per bead [69]. A classification laser
identifies the unique signature of each analyte region, and a reporter laser measures the
fluorescence intensity of the signal (Figure 1.5). The accuracy of this method is dependent on CV,
upper and lower limits of quantitation [70], and quality of the calibration curve but has shown
analytical performance comparable to a singleplex ELISA [71].
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Figure 1. 5. Bead-based ELISA. Microsphere beads have multiple antibodies immobilized to the
surface, corresponding to different antigens. A two-laser system consists of: (1) one detection to
measure emission of dye specific to each analyte, and (2) another detection to measure the emission
of Streptavidin-PE (or similar fluorophore) to measure the fluorescence intensity and quantify each
analyte. The multiplexed assay format proceeds similar to a traditional sandwich ELISA, but many
capture antibodies are immobilized on the surface. The biotinylated detection antibody shown in
blue recognizes a separate epitope of your desired analyte. The biotinylated detection antibody
then binds with the fluorescent reporter, streptavidin-phycoerythrin (shown in green), due to the
extremely high binding affinity of biotin for streptavidin. This image was modified with
permission from Vrana 2015 [72].

1.3.2 Dysregulation of cell signaling in other conditions
Disrupted cell signaling processes are common in many other conditions, such as
autoimmune disorders, cancer, and Alzheimer’s Disease, and investigating signaling networks has
led to advances in diagnostics and therapeutics for these pathologies. Here, a few examples are
discussed to highlight the potential for similar research to provide insight for chronic infections
like PJI.
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Cytokines IL-4 and IL-13 are potent initiators of allergic response, and the IL-4/IL13/STAT6 pathway is central to asthma modulating [73]. Elevation of these factors has been
observed in inflammatory airways of asthmatics, and some asthma drugs target IL-4/IL-13/STAT6
to suppress the inflammatory response. Targeting cell signaling pathways in asthma has not only
led to better drug targets, but differential network analysis has also revealed disparate hub genes
associated with inflammation, apoptosis, and T cell activity for allergic responses [74]. Networks
associated with various cancers have also been probed to identify new therapeutic targets. Many
cancers involve disrupted cell signaling, especially processes related to proliferation and survival.
Novel therapies for hepatocellular carcinoma have been reached through targeting of
Ras/Raf/MAPK [75], PI3K/AKT/mTOR [76], Wnt/β-catenin [77], and hedgehog signaling
pathways [78], four highly evolutionarily conserved pathways relevant to a number of critical
cellular processes. Recently, studies of Alzheimer’s Disease illustrated that new immune-related
targets HLA-B, IL-10, C1QB, and CD86 could be pursued to prevent disease and that disease
etiology of Alzheimer’s showed similarities to antigen presentation through network analysis [79].
Dissecting the complex signaling pathways in these conditions provided a better understanding of
the alterations to normal cell signaling provoked by disease states. These represent a few of the
many examples to illustrate the utility of investigating signal transduction networks in disease.

Bioinformatics approaches to understand complex biological responses
Biomarkers for diagnosis and treatment have been elucidated for many diseases, from
infection to autoimmune inflammatory disorders to cancer and beyond, and researchers employ
different statistical approaches and methodologies to understand these complex responses. It is
often advantageous to approach these using network analysis rather than traditional statistical
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testing like t-tests and ANOVAs, and studying chronic infection like PJI through network analysis
may provide a better understanding of the complex inflammatory environment. Network analysis
approaches can involve the integration of different data types and allow researchers to investigate
interactions of different targets involved (i.e., transcripts, proteins, metabolites) [80]. These
approaches have expanded on classical statistical techniques to probe beyond the investigation of
a single molecular entity. Recent accessibility of multi-‘omics technologies have made networkwide assessments more common when studying disease states, and new multi-‘omics studies of
disease have led to the discovery of biomarkers with higher specificity than those identified in
classical statistical testing (e.g., ANOVA, t-test, ROC), and this may be due to the ability to
consider the entire network as a whole rather than analyzing each target in isolation [81]. Database
searching software applications and mathematical modeling techniques have been utilized in a
variety of diseases to understand underlying molecular patterns of disease etiology.

1.4.1 Background on common network methodologies
Biological network analysis is central to understanding complex biological processes, and
recent technologies have shifted research towards large-scale biological datasets that measure
many parameters. Multi-‘omics studies (e.g., transcriptomics, genomics, proteomics,
metabolomics, interactomics) are the primary ways researchers approach network studies,
covering every portion of the journey from DNA to protein to protein-protein interactions in
signaling [82-84]. Ultimately, studying biological responses through these various platforms
allows a holistic view of cells and tissues to identify which targets are most important for survival
or death. High-throughput technologies like next-generation sequencing, microarrays, and hybrid
screening to identify interactions of biological network components have made it possible to
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collect a large amount of data with relative ease and allowed exponential growth of network
repositories and databases to aid in the analysis of cellular network data. Cutting-edge mass
spectrometry techniques allow for global assessment of proteins, metabolites, and other species of
interest in biological samples [85]. The advent of multi-‘omics approaches has paved an exciting
path forward, allowing for a more complete understanding of complex biological interactions.
These technologies can be applied for biomarker identification [86], drug discovery [87], and in
the future of personalized medicine [88].

Researchers that take advantage of these techniques produce hearty data sets with large
amounts of information, but this presents a problem of its own: what is the best way to analyze,
integrate, and interpret the data? Biological networks and interactions of proteins within the
network can be constructed from literature-derived and experimental data. Additionally, data can
be acquired in many forms, including protein-protein interactions, protein function prediction,
association with canonical networks, and more. Some commonly-used network methodologies are
based on graph theory, Bayesian approaches, and correlations to draw connections between
individual targets to form a network [81]. These approaches can be used to answer a wide range
of biological questions concerning genetic causes of disease, target identification for biomarkers
of drug discovery, and monitoring of treatment [89].

1.4.2 Databases and model repositories
Databases and repositories are commonly used in biological network analysis, and they often
take both literature-derived data and the researcher’s experimental data into account. Many
databases exist primarily to analyze network data, and the researcher must consider the nature of
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the data, application, and interpretation when deciding which database(s) to utilize. Model
organisms, tissue types, and diseases may also be considered; databases and model repositories
are carefully curated, but some may be more appropriate for different etiologies [90]. These
network-based studies are often carried out in model organisms, including both in vitro and in vivo
research. These are considerations when choosing which database(s) to use and what caveats must
be acknowledged when interpreting the data. Some examples include the Reactome Pathway
Knowledge Base [91], KEGG genome database [92], Gene Ontology (GO) GOnet [93], Ingenuity
Pathway Analysis (IPA) [94], and Cytoscape [95]. Most of these tools rely on basic statistical tests
to identify significant targets. Reactome uses a simple binomial test to calculate significant
deviations from expected observations and create links between different entities. KEGG and GO
use hypergeometric probabilities to enrich data sets by identifying associations with individual
nodes of interest. IPA connects individual targets through Fisher’s Exact Test to construct a
network of biological nodes. Some tools, like Cytoscape, allow the user to have more control over
the tests for significance, which provides more flexibility when working with different types of
data. Databases differ in analysis methods, so researchers must thoroughly understand what
information the database can provide and its limitations. Some common databases and repositories
used to interpret biological networks are discussed in the following paragraphs.

Systems biology approaches have centered around network analysis, and these techniques
have demonstrated broad utility in addressing questions of disease etiology to therapeutics, making
them extremely attractive to researchers. Studies cover a wide range of data types, collection
methods, statistical analysis approaches, and aims, demonstrating the highly diverse studies that
benefit from network analysis techniques. Network analysis using databases and repositories have
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led to better targets for cancer therapeutics [96], a better understanding of the immune response to
asthma [97], and biomarkers of disease progression in Amyotrophic Lateral Sclerosis (ALS) [98],
to name a few of the many pathological states that have been investigated. While it is often
advantageous to use network approaches, problems can arise due to insufficiencies in data related
to a particular model organism, the number of relevant studies in the database for a specific disease,
and lack of spatial and temporal information (i.e., mismatches in time points or distance from
injury) [89]. Progress in data analysis in the future will depend on broadening the model organisms
and scopes of disease, including the inclusion of multiple ‘omics platforms for diseases. The more
data within the repositories these databases use, the more accurate the machine learning algorithms
can become, ultimately providing better answers to systems biology questions. Network
approaches have expanded the knowledge of biological systems and have proven to be an essential
asset for the future of signal transduction research.

1.4.3 Advanced mathematical network analysis approaches
The use of biological network applications to analyze a dataset is highly beneficial for
many researchers, especially in disease states that have been well studied. Challenges can arise
when investigating diseases that have not been well characterized and only have a small number
of studies relevant to signal transduction mediators. For these cases, advanced statistical
techniques like mathematical modeling offer an alternative, as they rely solely on the parameters
the investigator includes. Network centrality is one approach, and it is based upon graph theory,
which mathematically organizes the different parameters to create a “map” of their interactions
and interconnectivity [99]. In graph theoretical analysis, the network consists of nodes and edges.
Nodes are parameters within the network (i.e., proteins, genes, metabolites), and edges represent
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the interactions of node pairs. Using graph theory, researchers can characterize the biological
network by connecting nodes and assigning quantitative values to their influence on the network
as a whole. A common approach for interpretation of these networks is to analyze through a lens
of network centrality, as this can properly weight the interactions of the network, providing
information on highly interconnected nodes vs. peripheral nodes, which can then be interpreted
for their biological roles [100].

Many other advanced mathematical modeling and statistical techniques have been
employed to analyze networks, including principal component analysis (PCA), partial least squares
discriminant analysis (PLS-DA), and hierarchical clustering [101]. These techniques reduce the
dimensions of the dataset and combine parameters to model the system, thereby significantly
reducing the complexity and allowing interpretation. Predictive modeling can be integrated into
these techniques to evaluate the model’s ability to accurately group proteins, genes, etc., to
describe an altered biological state. New tools that utilize advanced statistical principles to dissect
large biological network data are being developed in the field, and many of them are based upon
these techniques. For example, new statistical strategies have been employed to integrate multi‘omics data based on orthogonal PLS approaches, illustrating the potential to narrow variables of
interest [102]. The probabilistic modeling technique ProbRules was developed to predict the
behavior of dynamic signaling networks based on differential equations, allowing the ability to
focus wet-lab experiments a priori [103]. Williams et al. developed a “functional heatmap” to
quickly assess time-series multi-‘omics data based on cluster analysis, providing the means to
quickly assess patterns in large data sets [104]. These represent only a few examples of the
possibilities of new tools developed to support signal transduction research. At their cores,
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traditional multivariate statistical approaches laid the foundation for these tools and allowed
researchers to expand their use to handle multi-‘omics data sets.

Choosing which mathematical technique is appropriate for a data set is dependent on the
format of the data, desired outcomes, and goals of the research. All of the described analysis
methods have been proven in the literature to manage large, complex biological datasets, and
researchers are developing new techniques to integrate multi-‘omics data sets for their own
purposes. As multi-‘omics techniques become more widely adopted for studies of biological
networks, network analysis through database searching, mathematical modeling, and repositories
highlight a new frontier to dissect complex biological milieu to understand diseases like chronic
infection.

The work presented in the following chapters describes comparisons of immune-related
cytokines and wound healing phosphoproteins in response to implants and infection in order to
understand cell signaling changes in response to these stimuli. Based on previous work to
understand cytokine responses in PJI on a serum level [52, 53], the prevailing hypothesis was that
higher concentrations of cytokines would be present in septic tissues, and these could be developed
into tissue-level biomarkers of infection. Phosphoproteins related to wound healing processes were
also tested to probe the interactions between inflammatory immune cytokines and tissue healing
mediators. The purpose of this work was to provide a novel tissue-level investigation to provide
new insights into changes related to implants and chronic infection.
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2. Localized Cytokine Responses to Total Knee Arthroplasty and Total Knee Revision
Complications1
The study of localized immune-related factors has proven beneficial for a variety of
conditions, and one area of interest in the field of orthopaedics is the impact of implants and
localized infections on immune response. Several cytokines have shown increased systemic
concentrations in serum/plasma due to implants and infection, but tissue-level cytokines have not
been investigated as thoroughly. This exploratory study investigated tissue-level cytokines in a
cohort of patients (N=17) in response to total knee arthroplasty and total knee revision to better
understand the immune response to implants and localized infection (e.g., prosthetic joint
infection). The overall goal of this study was to provide insight into the localized cytokine response
of tissues and identify tissue-level markers specific to inflammation caused by implants versus
inflammation caused by infection. Tissues were collected across several anatomical locations and
assayed with a panel of twenty human inflammatory cytokines to understand spatial differences in
cytokine levels. In this study, six cytokines were elevated in implanted joints, as compared to
native joints: IL-10, IL-12p70, IL-13, IL-17A, IL-4, and TNF-α (p<0.05). Seven cytokines showed
infection-dependent increases in localized tissues: IL-1α, IL-1β, IL-6, IL-8, MCP-1, MIP-1α, and
MIP-1β (p<0.05). This study demonstrated that differences exist in tissue-level cytokines in
response to presence of implant, and some cytokines were specifically elevated for infection; these
responses may be informative of overall tissue health. These results highlight the utility of
investigating localized cytokine concentrations to offer novel insights for total knee arthroplasty
and total knee revision procedures, as well as their complications. Ultimately, this information

1 Parts of this chapter have been published previously from Prince N, Penatzer JA, Dietz, MJ, and Boyd, JW.
Localized Cytokine Responses to Total Knee Arthroplasty and Total Knee Revision Complications. Journal of
Translational Medicine. 18, 330 (2020).
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could provide additional, quantitative measurements of tissue to aid clinical decision making and
patient treatment options.
Introduction
The inflammatory response to infection involves a series of biological events regulated by
a number of immune mediators, and the actions of these immune factors are partially reliant on
the cytokines and chemokines produced in response to pathogens, foreign bodies, and other stimuli
[1-3]. These responses are of interest to the field of orthopaedics, especially with regard to the
immune response to implants, infection, and chronic inflammation [4-6]. An elevated immune
response has been observed following total knee arthroplasty (TKA) procedures, and increased
levels of cytokines, particularly interleukin (IL)-1, IL-4, IL-6, IL-10, and tumor necrosis factor
alpha (TNF-α), have been observed on a systemic level (i.e., serum/plasma) as well as on a more
localized level (i.e., synovial fluid) [7-9]. However, many aspects of this response are not well
understood, so the inflammatory response in orthpaedic implants and implant infections remain
uncharacterized. A majority of TKA procedures are successful, but implant-related and infectionrelated complications can negatively affect a patient’s quality of life. Properly addressing these
issues is of high priority to the field of orthopaedics, especially considering the increasing demand
for joint replacement [10]. Many studies have noted the pain, inflammation, and dissatisfaction
that can occur following these procedures, affecting approximately 20% of patients undergoing
TKA [11, 12], but it is not entirely known what role cytokines play in this chronic inflammatory
response.

Infections, such as prosthetic joint infection (PJI), are serious complications and the source
of excessive joint inflammation, leading to higher rates of total joint failure [13]. PJI is a localized
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infection surrounding a prosthetic joint and can result following implantation, often necessitating
surgical intervention [14]. PJI is a major concern following TKA/total knee revision (TKR)
procedures and can be difficult to treat. The infections are often persistent and unable to be
resolved using conventional methods, presenting a challenge for clinicians [15]. The systemic
immune response to PJI has been studied extensively, but the localized tissue response is not as
well understood. In order to better understand the immune response to implants and localized
infection, this study investigated levels of twenty inflammatory cytokines in localized tissue
surrounding the joint. While defining the localized response to implants and infection can be
difficult [7-9], localized cytokine responses have been investigated for other pathological
conditions. A few studies have characterized localized cytokine responses in trauma [16-18] and
respiratory infection [19], and these studies demonstrated that the local cytokine environment
differs when compared to systemically circulating levels. Currie et al. showed that differences in
cytokine concentrations exist in skeletal muscle samples in a spatially-dependent manner using an
animal model of traumatic injury [16]. Similarly, Hauser et al. observed differences in levels of
cytokines at the site of injury compared to systemic levels in response to trauma in humans [18].
Other research groups have observed spatially-related differences of other immune-related factors
for stroke [20], and in response to allergens [21] in animal models. These studies introduced the
concept of using immune markers on a localized level to better understand these conditions.

TKA and TKR procedures trigger inflammatory cascades, initiating cytokine responses
and elevating systemic cytokine concentrations; higher levels of cytokines have been observed
following these surgeries. The elevation in cytokine levels has been attributed to the trauma of
surgery as well as the introduction of implants into the body [22, 23]. However, this inflammation
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is sometimes prolonged, which can cause major complications for patients. The causes of chronic
inflammation following these procedures are still unknown, and resolution of the inflammation is
challenging [24]. Therefore, understanding the changes in inflammatory response specific to
implant-related inflammation is beneficial to improving the outcome of these individuals.

Tissue-level response to PJI has not been characterized to understand the local immune
modulation in these cases. Many studies have investigated systemically circulating levels of
interleukins and other cytokines for their roles in infection, and several cytokines are used as
diagnostics of PJI [25-27]. Several studies have specifically focused on the utility of measuring
IL-6 and IL-8 levels in serum for diagnosing and monitoring PJI, both of which have increased
specificity over conventional methods; this knowledge has greatly benefitted the clinical treatment
options for PJI [28, 29]. However, PJI remains one of the most serious complications following
revision knee arthroplasty. In fact, infection is one of the most common causes for revision, being
implicated in 20.4% of all revision TKA procedures between 2009 and 2013 [30]. While defining
the systemic response to sepsis and infection has paved the way for improved diagnostics [31-33],
less is known about the environment of localized infections and what role cytokines play in
determining tissue health.

The present study focused on understanding differences in localized distributions of
cytokines in TKA and TKR procedures, with and without presence of infection, using PJI as the
model for localized infections. The ultimate goal of this study was to characterize the immune
modulation on a tissue level that occurs in response to joint implantation and infection to better
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understand localized tissue health. The information gained could aid clinical management of these
complications by narrowing down cytokines that are indicative of response to PJI. It represents the
first known investigation of tissue-level cytokines in response to implant-related and infectionrelated complications, to our knowledge.

Materials and methods
2.2.1 Patient cohort
Following Institutional Review Board (IRB) approval (IRB Protocol #1709745853) and
patient consent, six patients undergoing primary total knee arthroplasty (TKA) and eleven patients
undergoing total knee revision (TKR) procedures participated in the study (8 males, 9 females;
aged 45-82 years; body max index [BMI] 24.6-43.7). Subjects were recruited over a 12-month
period. All six primary TKA patients were undergoing elective surgery for total replacement of
the knee joint with a diagnosis of osteoarthritis. At the time of this study, this was the first
arthroplasty procedure on either knee joint. In the TKR group, patients were further characterized
into aseptic and septic revision procedures. Patients with aseptic revisions (N=5) were undergoing
revisions due to failures of the prosthetic joint but did not show presence of infection. For ease of
the reader, samples from these patients will be referred to as aseptic TKR tissues. Patients with
septic revisions (N=6) met clinical criteria for a PJI diagnosis as defined by the Musculoskeletal
Infection Society (MSIS) criteria [13]. Samples from these patients will be referred to as septic
TKR tissues. All six patients diagnosed with PJI were tissue culture positive: four tested culture
positive for Staphylococcus epidermidis, one for Methicillin-sensitive Staphylococcus aureus
(MSSA), and one for Enterobacter cloacae. More patient information can be found in Table 2.1
below. Systemic C-reactive protein (CRP) levels in serum are additionally listed as reference.
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Table 2. 1. Patient Information. Six primary TKA and eleven revision TKR patients were enrolled
in the study, creating a heterogenous cohort of males and females varying in age (45-82 years) and
comorbidities. Primary TKA patients have ID format P#; revision TKR patients have ID format
F#. This table lists general patient information including the pathogen for which each septic patient
tested culture-positive following testing on the day of surgery. Serum CRP values were obtained
pre-operatively in the revision setting. Cultures were obtained from intraoperative tissue samples.

ID

Sex

TKA/TKR

BMI(kg/m2)

Diabetic (Y/N)

CRP (mg/L)

Culture

P1

F

TKA

33.8

N

N/A

Negative

P2

F

TKA

39.8

N

N/A

Negative

P3

F

TKA

39.8

N

N/A

Negative

P4

M

TKA

29.7

Y

N/A

Negative

P5

M

TKA

24.6

N

N/A

Negative

P6

M

TKA

27.2

N

N/A

Negative

F1

F

TKR- Aseptic

28.2

N

4.3

Negative

F2

F

TKR- Aseptic

29.8

N

0.2

Negative

F3

F

TKR- Aseptic

33.9

N

<1

Negative

F4

M

TKR- Aseptic

40.4

Y

3.6

Negative

F5

M

TKR- Aseptic

26.2

N

2.1

Negative

F6

F

TKR- Septic

43.7

N

28.8

S. epidermidis

F7

F

TKR- Septic

30.8

Y

161.4

S. epidermidis

F8

F

TKR- Septic

41.9

N

21.7

E. cloaecae

F9

M

TKR- Septic

36.2

N

33.5

MSSA

F10

M

TKR- Septic

33.8

Y

3.8

S. epidermidis

F11

M

TKR- Septic

31.9

N

111.9

S. epidermidis
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2.2.2 Collection of tissue samples
All TKA and TKR procedures were performed by a single surgeon with standard
debridement and washing protocols. Tissues were collected at a total of four distinct anatomical
locations, broadly characterized into two tissue layers: four adjacent tissue layer (ATL) samples
and three radial tissue layer (RTL) samples. The ATL samples came from the initial debridement.
Tissues from the ATL layer were closer to the knee joint (or prosthetic implant). Conversely, RTL
samples were taken from a tissue layer further removed from the joint (or prosthetic implant) after
the surgeon completed debridement. The difference in depth of the RTL tissues and ATL tissues
was approximately 5-10 mm and was dependent on the individual patient. Measurements were
made from point of origin to standardize tissue samples taken between patients. Tissues were taken
at four anatomical locations illustrated in Figure 2.1. Briefly, the solid line circle represents
location 1) medial femoral condyle (F); the dashed line circle represents location 2) medial tibial
plateau (T); the solid line square represents location 3) lateral gutter (LG); and the dashed line
square represents location 4) posterior capsule (PC). Anatomical locations 1-4 were collected for
the ATL layer, and locations 1-3 were collected for the RTL layer. Location 4, PC, could not be
taken in the RTL layer due to proximity to neurovascular structures. Therefore, a total of seven
tissue samples were taken for each patient.
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3
4

1

2

Figure 2. 1. Map of approximate tissue collection locations, shown with prosthetic implant
illustrated. Seven tissue samples were taken for each patient; 1) the solid circle represents the
medial femoral condyle (denoted as F); 2) the dashed circle represents the medial tibial plateau
(denoted as T); 3) the solid square represents the lateral gutter (denoted as LG); 4) the dashed
square represents the posterior capsule (denoted as PC). Locations 1-4 were taken for the ATL
layer, and locations 1-3 were taken for the RTL layer; separation between ATL (closer to joint)
and RTL (further from joint) was approximately 5-10 mm, depending on individual patient.

2.2.3 Sample preparation
Tissues were collected during TKA and TKR procedures in the operating room and
immediately stored on dry ice. Once all tissues had been collected for an individual patient, they
were washed with 1X cold phosphate-buffered saline (PBS) to remove blood and debris. Tissues
were grossly dissected using a scalpel to remove scar tissue or cement, then stored at -80 ºC. When
samples had been collected for all patients, tissues were thawed on ice and cut into sections
approximately 30 mg in size; tissues were homogenized by sonication in 500 µL cell lysis solution
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(Bio-Rad, Hercules, CA) containing 20 mM phenylmethylsulfonyl fluoride (Sigma-Aldrich, St.
Louis, MO). Protein extraction was performed using methods adapted from Hulse et al. [34].
Thawed samples were vortexed for 1-3 s and centrifuged at 5,000 x g for 5 minutes at 4 °C. The
supernatant was collected and tested for total protein content using a Pierce BCA Protein Assay
Kit (Thermo Scientific, Waltham, MA), according to manufacturer’s instructions. Absorbance
values for total protein content were determined on an Infinite M1000 multimode plate reader
(Tecan, Raleigh, NC).

2.2.4 Cytokine measurement
To standardize samples for total protein content, tissue homogenates were individually
diluted to a total protein concentration of 900 µg/mL with cell lysis buffer (Bio-Rad). Cytokine
quantification was performed using a magnetic bead-based multiplex Inflammation Human
ProcartaPlex panel assay (Invitrogen, Carlsbad, CA) and measured using a Bio-Plex 200
suspension array system and Pro II Wash Station (Bio-Rad), according to the manufacturer’s
instructions. Cytokine concentrations were averaged to represent values for the ATL and RTL.
Four tissues were averaged to calculate ATL average (LG, F, T, PC), and three tissues were
averaged to calculate RTL average (LG, F, T). A table of cytokine values at ATL and RTL and
graphs of cytokine concentrations at individual tissue locations are available in Appendix A.

2.2.5 Statistical analysis
Data were analyzed using Prism 5 (GraphPad, San Diego, CA) and SAS JMP (Cary, NC).
Standard curves were generated for each protein using either a four- (4PL) or five-parameter
logistic (5PL) regression model, depending on the individual protein. Cytokine concentrations
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were determined using standard curve interpolation, then corrected by dilution factor to compare
tissue homogenates. Cytokine concentrations are expressed as picograms of cytokine per milliliter
of tissue homogenate (pg/mL). Samples with fluorescence intensity values below the lower limit
of quantitation (LLOQ) or above the upper limit of quantitation (ULOQ) were omitted from
statistical comparisons. Outliers were identified using the 1.5 X interquartile range (IQR) rule and
omitted from analysis. Two-way analysis of variance (ANOVA) with Bonferroni’s post-test was
used to determine significant differences between primary TKA, aseptic TKR, and septic TKR
tissue samples at each tissue location. Each tissue homogenate was tested in duplicate for cytokine
concentration. Data are expressed as the mean ± standard error of the mean (SEM).

Quadratic discriminant analysis was conducted to evaluate the combined capacity of
cytokine response to predict the state of tissue. Using SAS JMP, all measured responses were cast
as covariates, and the “group” was assigned as a classification category (primary TKA, aseptic
TKR, septic TKR). The Shrink Covariances option was applied to account for the different
covariances within the categories. Quadratic discriminant analysis is a predictive modeling tool,
and when there are a large number of variables compared to observations, as is the case in this
study, Shrink Covariances is frequently employed to improve the stability and reduce prediction
variance [35]. This analysis included 13 covariates; only those cytokines that produced statistically
significant two-way ANOVA comparisons for either infection-specific or implant-specific
comparisons were included: IL-1α, IL-1β, IL-6, IL-8, monocyte chemoattractant protein (MCP)1, macrophage inflammatory protein (MIP)-1α, MIP-1β, IL-10, IL-12p70, IL-13, IL-17A, and
TNF-α. Biplot rays are plotted to indicate how each covariate influences the canonical space, with
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the direction and magnitude signifying the degree of association with the respective group (primary
TKA, aseptic TKR, septic TKR).

Due to the limited sample size, this study was not able to control for age, sex, BMI, or other
comorbidities. Pearson correlations were run between cytokine concentrations and age, sex, and
BMI for each patient to analyze the contribution of these variables. Bonferroni’s correction was
applied to correct for multiple inferences, as previously described by Bland et al. [36].

Results
Changes in cytokine concentrations were observed for comparisons of primary TKA vs.
aseptic TKR vs. septic TKR tissues. Overall, cytokine concentrations were generally elevated in
TKR (both septic and aseptic) compared to TKA, and septic TKR exhibited higher cytokine levels
than aseptic TKR for several cytokines. Seven cytokines (IL-1α, IL-1β, IL-6, IL-8, MCP-1, MIP1α, and MIP-1β) showed increased concentrations in septic TKR tissues compared to both aseptic
TKR tissues and primary TKA tissues (p<0.05). Six cytokines (IL-10, IL-12p70, IL-13, IL-17A,
IL-4, and TNF-α) showed differences in concentration between primary TKA and TKR (both
aseptic and septic) (p<0.05), but these six cytokines were not significantly different between
aseptic TKR and septic TKR. These comparisons are described in detail over the following
sections. Additional human inflammatory cytokines were tested, but they did not produce
statistically significant comparisons at p<0.05 in this study: E-Selectin, granulocyte-macrophage
colony-stimulating factor (GM-CSF), interferon-alpha (IFN-α), interferon-gamma (IFN-), and
interferon gamma-induced protein 10 (IP-10).
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2.3.1 Seven cytokines exhibited infection-specific elevations in concentration
Seven cytokines showed an increase in concentration that was dependent on the presence
of localized infection: IL-1α, IL-1β, IL-6, IL-8, MCP-1, MIP-1α, and MIP-1β (p<0.05). For these
cytokines, primary TKA averages were lowest, with an increase in aseptic TKR and further
increase in septic TKR. For IL-1α, the average concentration of primary TKA tissues was
1.1 pg/mL, and rose to 11.8 pg/mL in aseptic TKR; the concentration was elevated to 30.3 pg/mL
in septic TKR. Further, in the septic TKA group, there was a statistically significant difference
between ATL and RTL averages (p<0.05). IL-1β showed a similar trend, with a mean of 1.7 pg/mL
in primary TKA tissues, which rose to 5.4 pg/mL in aseptic TKR, and further elevated to
39.1 pg/mL in septic TKR. IL-1β also reflected the spatial disparity in concentration between ATL
and RTL in the septic TKR group (Fig. 2.2). IL-6 followed, with an average of 8.5 pg/mL in
primary TKA, rising to 24.2 pg/mL in aseptic TKR, and finally 610.7 pg/mL in septic TKR. IL-8
levels were 7.6 pg/mL in primary TKA, which increased to 91.1 pg/mL in aseptic TKR, and rose
to 553.9 pg/mL in septic TKR. For MCP-1, the average of primary TKA tissues was 113.0 pg/mL,
which increased to 258.8 pg/mL for aseptic TKR, and further increased to 565.1 pg/mL for septic
TKR. MIP-1α followed the same trend, with an average of 7.8 pg/mL for primary TKA, which
rose to 27.8 pg/mL in aseptic TKR, and was elevated to 81.6 pg/mL in septic TKR. ATL locations
showed the most significant increases in MIP-1α between groups (Fig. 2.2, p<0.05). For MIP-1β,
primary TKA tissues showed an average of 21.3 pg/mL and were increased to 46.0 pg/mL for
aseptic TKR and further increased to 123.4 pg/mL in septic TKR. As shown in Figure 2.2, cytokine
concentrations in the ATL layer locations were generally higher than the RTL layer locations for
all of these cytokines except MCP-1.
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Figure 2. 2. Seven cytokines showed infection-dependent elevation in localized tissues. Average
cytokine concentration for ATL and RTL are shown for all groups. Two-way ANOVAs with
Bonferroni’s post-test were conducted to test for significant differences between groups at each
tissue depth (p<0.05). Significant differences between groups at a particular location are marked
as: P denotes significant difference from primary TKA (N=6); A denotes significant difference
from aseptic TKR (N=5); S denotes significant difference from septic TKR (N=6); all symbols
denote significance at the p<0.05 level.
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2.3.2 Six cytokines exhibited implant-related elevations in concentration (Primary TKA
vs. Aseptic/Septic TKR)
Six cytokines, IL-10, IL-12p70, IL-13, IL-17A, IL-4, and TNF-α, exhibited higher levels
in TKR tissues as compared to primary TKA tissues ( Fig. 2.3 p<0.05). In other words, there were
significant differences (p<0.05) between primary TKA and aseptic/septic TKR, but there were no
significant elevations in concentration from aseptic TKR to septic TKR. For IL-10, the average
value in primary TKA was 0.9 pg/mL, 8.4 pg/mL in aseptic TKR, and 6.6 pg/mL in septic TKR.
With the same general trend, IL-12p70 had an average of 5.7 pg/mL in primary TKA, 30.7 pg/mL
in aseptic TKR, and 20.7 pg/mL in septic TKR. For IL-13, the average in primary TKA was
1.8 pg/mL, 9.6 pg/mL in aseptic TKR, and 9.9 pg/mL in septic TKR. Following this trend, IL-17A
average concentrations were 5.3 pg/mL in primary TKA, 16.3 pg/mL in aseptic TKR, and
18.9 pg/mL in septic TKR. For IL-4, average concentration in primary TKA was 6.9 pg/mL, which
rose to 19.6 pg/mL in aseptic TKR, and further to 24.8 pg/mL in septic TKR. Finally, TNF-α
followed the same trend, with an average concentration of 16.9 pg/mL in primary TKA,
71.1 pg/mL in aseptic TKR, and 86.8 pg/mL in septic TKR. None of these six cytokines showed
significant spatial disparities between the ATL and RTL layers at p<0.05.
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Figure 2. 3. Six cytokines showed implant-related elevation in localized tissues that was not
infection-dependent. Average cytokine concentrations for ATL and RTL are shown for all groups.
Two-way ANOVAs with Bonferroni’s post-test were conducted to test for significant differences
between groups at each tissue depth (p<0.05). Significant differences between groups at a
particular location are marked as: P denotes significant difference from primary TKA (N=6); A
denotes significant difference from aseptic TKR (N=5); S denotes significant difference from
septic TKR (N=6); all symbols denote significance at the p<0.05 level.
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2.3.3 Quadratic discriminant analysis (QDA) cytokine profiles for TKA vs. TKR
The two-way ANOVA comparisons of cytokines between different groups revealed seven
cytokines that showed infection-specific elevation (beyond inflammation caused by implants), and
six cytokines that showed increases due to implants, but not infection (Figures 2.2 and 2.3). To
further probe the structure of these cytokine profiles between groups, quadratic discriminant
analysis was conducted. These thirteen cytokines were included as covariates. The analysis
classified the combined observed responses into pre-determined groups of primary TKA, aseptic
TKR, and septic TKR. The group was predicted based on the covariate responses associated with
each group, respectively. For each group, all seven locations were included for all individuals in
that group, which means there were 42 counts for primary TKA (7 tissue locations, 6 patients), 35
values for aseptic TKR (7 tissue locations, 5 patients), and 42 counts for septic TKR (7 tissue
locations, 6 patients). In total, of 119 counts, only 8 were misclassified, indicating a good
prediction ability of the model. All 8 misclassifications were errors of a prediction of aseptic TKR
group, when the values were originally from the septic TKR group. In other words, these
individuals were falsely classified as aseptic based on cytokine profiles while they were actually
septic. Further, there is overlap between the 95% confidence intervals for cytokine profiles of
aseptic TKR and septic TKR patients (Figure 2.4), which may be responsible for the
misclassification.
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Figure 2. 4. Quadratic discriminant analysis (QDA) revealed distinct groupings for primary TKA
vs. TKR (aseptic or septic). Cytokines with significant infection-dependent or implant-related
elevations via two-way ANOVA were analyzed via quadratic discriminant analysis. Canonical
scores for each cytokine (covariate) were calculated, and the 95% confidence interval is shown for
primary TKA (green), aseptic TKR (red), and septic TKR (blue). The + symbol represents the
mean of each group. Biplot rays describe the degree of association of a certain cytokine with
canonical variables.
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2.3.4 Effects of age, sex, and BMI on cytokine concentrations
The research presented here did not control for age, sex, or BMI due to the limited sample
size of this exploratory study. To better understand the connections between cytokines of interest
(IL-1α, IL-1β, IL-6, IL-8, MCP-1, MIP-1α, MIP-1β, IFN-γ, IL-10, IL-13, IL-17A, IL-4, and TNFα) and these factors, Pearson correlations were run and analyzed for statistical significance. When
the Bonferroni’s correction was applied, as described in [36], none of the correlations between
cytokine levels and age, sex, or BMI were significant (p>0.05), but the correlations are displayed
in Table 2.2 for transparency. Although there is an established connection in the literature between
inflammatory cytokine levels and age, sex, and BMI, the lack of significant Pearson correlation pvalues indicates these were not confounding variables for this study [37-39].
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Table 2. 2. Pairwise Pearson Correlation Values Between Cytokine Concentrations and Age, Sex,
and BMI. The pairwise correlation values are listed for each of the three groups: primary TKA,
aseptic TKR, and septic TKR. Pearson correlation values are rounded to two decimal places. No
correlations were found to be significant at the p<0.05 level after Bonferroni’s correction.

Primary TKA

Aseptic TKR

Septic TKR

Cytokine

Age

Sex

BMI

Age

Sex

BMI

Age

Sex

BMI

IL-1α

0.00

0.47

0.28

0.20

0.22

-0.54

-0.15

0.25

-0.05

IL-1β

-0.19

-0.06

-0.04

-0.30

-0.30

0.08

0.03

0.26

0.05

IL-6

0.00

-0.09

-0.12

0.03

-0.19

-0.21

0.00

0.22

-0.02

IL-8

0.03

0.59

0.25

0.06

-0.07

-0.32

-0.13

0.14

-0.14

MCP-1

0.04

0.13

0.14

-0.18

-0.44

0.45

-0.07

0.20

-0.15

MIP-1α

-0.10

0.13

-0.04

-0.05

-0.30

0.09

0.33

0.08

-0.13

MIP-1β

-0.04

0.19

0.03

0.23

-0.06

-0.38

0.21

0.13

-0.16

IL-10

-0.26

0.29

0.17

-0.31

0.00

-0.20

-0.11

-0.25

0.30

IL-12p70

-0.06

0.02

0.03

-0.03

0.49

-0.32

-0.30

-0.18

0.33

IL-13

-0.19

0.49

0.28

-0.06

0.41

-0.06

-0.22

-0.23

0.22

IL-17A

0.00

-0.08

-0.31

0.31

0.85

-0.45

-0.34

0.06

0.32

IL-4

-0.32

0.20

0.29

0.34

0.35

-0.55

0.21

0.02

-0.11

TNF-α

-0.22

0.34

0.25

0.45

0.72

-0.38

-0.45

-0.12

0.25
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Discussion
Understanding inflammation in response to implants and infection following TKA and
TKR procedures is a high priority for clinicians, as excessive inflammation can cause serious
problems for patients. However, not much is known about the local immune response in these
complex environments. While a variety of cytokines have been researched from a systemic view
[40, 41], their clinical use is still debated [31-33, 42], and the cytokine responses have not been as
well characterized on a localized tissue level. The tissue-level cytokine response may add further
understanding of the localized environment and give insight into tissue health to aid clinicians in
the management of these post-surgical complications. Tissue-level cytokines have been measured
with respect to spatial gradients in traumatic injury [16-18], respiratory infection [19], stroke [20],
and allergic response [21], and these studies provided useful information regarding the respective
immune responses. These have established a basis for this study to investigate the use of cytokines
to enlighten tissue viability following localized implant-related and infection-specific
inflammation.

This study focused on defining the tissue-level cytokine response to implants and infection
across several anatomical locations. Many human inflammatory cytokines have been implicated
in the systemic response to implants (i.e., in serum/plasma) [43-45] and now aid in diagnosis of
infection [46, 47]. However, this investigation is the first, to our knowledge, to assess multiple
tissue locations surrounding the joint to address implant-related vs. infection-specific responses.
Seven cytokines were identified as infection-specific, showing elevated concentrations in the
septic TKR cohort compared to both the aseptic TKR and primary TKA cohorts: IL-1α, IL-1β, IL6, IL-8, MCP-1, MIP-1α, and MIP-1β (p<0.05). Several of these cytokines have demonstrated
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utility in previous studies for diagnosis of PJI (i.e., IL-1α, IL-1β, IL-6, IL-8), but this is the first
instance of their investigation for tissue health and debridement [30-33]. Generally, these seven
cytokines were elevated in the ATL depth compared to RTL, which brings to light the importance
of proximity to joint in dictating cytokine response. Pro-inflammatory cytokines like IL-1α, IL-1β,
IL-6, and IL-8 have been noted for their roles in early infection response, producing a warning
signal of pathogen invasion, and this response was present in septic TKR tissues [48, 49]. These
early cytokine indicators recruit factors like MCP-1, MIP-1a, and MIP-1b that propagate the
response to pathogens through Th1 and Th2 immune signaling cascades [50, 51]. IL-1α and IL-1β
in particular showed a statistically significant elevation in the ATL of the septic TKR group
compared to the RTL of the septic TKR group, which suggested that these cytokines may be
capable of distinguishing healthy and unhealthy tissue in PJI.

Six cytokines were showed implant-related increases in concentration, with elevations in
aseptic and septic TKR vs. primary TKA: IL-10, IL-12p70, IL-13, IL-17A, IL-4, and TNF-α
(p<0.05). The elevated concentrations of these cytokines highlighted the degree of inflammation
in implanted joints without the presence of infection, which is likely due to the presence of a
foreign body. The implant-related inflammation reflected less of the macrophage activation
present in the septic TKR group but exhibited elevation in anti-inflammatory cytokines like IL-10,
IL-4, and IL-13 frequently associated with bone healing [7]. IL-17A and IL-12p70 have both proand anti-inflammatory roles, but the specific contributions to foreign body response are not well
understood. Increased levels of these cytokines, as well as TNF-α, implies there may be
dysregulation of inflammatory response due to implant. These cytokines were not significantly
different in the septic TKR group compared to aseptic TKR at the p<0.05 level, so they may be
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considered as indicators of aseptic or chronic inflammation that could be addressed with future
research associated with TKA. The QDA analysis illustrated that cytokine profiles are distinct
between all three cohorts, but there is significant overlap in the 95% confidence intervals of aseptic
TKR and septic TKR. While there are several cytokines that distinctly separate these two cohorts,
this analysis indicated that the degree of inflammation experienced between these groups is
comparable. This finding agrees with the clinical decision to address inflammation and perform
revision surgery, and these markers (IL-10, IL-12p70, IL-13, IL-17A, IL-4, and TNF-α) may show
promise as helpful diagnostic monitoring markers for patients suffering from inflammatory
complications in the absence of infection.

While this study had several limitations (i.e., single operating surgeon, heterogeneous
cohort of patients, pathogen variability), it represents a novel characterization of tissue-level
cytokines across different anatomical locations in response to implants as well as infection-specific
inflammation. These cytokines may give insight into the health of localized tissue following these
procedures, and the results highlight the utility of investigating a localized view of tissue health by
testing tissues surrounding the joint following these procedures. At the time of publication, all
patients had reached at least the one-year post-operative follow up without need for revision with
no recurrent infections, and the predictive value of these cytokines for successful surgical
outcomes is of interest in future studies. These cytokines could potentially be incorporated to intraoperatively assess the degree of inflammation during surgery, providing information in real time
about the viability of tissues for debridement. A more focused investigation of infection-specific
markers IL-1α, IL-1β, IL-6, IL-8, MCP-1, MIP-1α, and MIP-1β could provide insight into the
power of these cytokines to discriminate aseptic vs. septic tissues.
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Conclusions
In conclusion, this exploratory pilot study identified several cytokines that exhibited higher
concentrations in response to implant-related and infection-specific post-operative inflammation.
Some of these cytokines have been previously implicated in chronic inflammation and infection
following TKA and TKR on a systemic level [11, 12, 30-33], and this study confirmed this trend
on a localized tissue level and identified implant-related and infection-specific tissue-level
cytokines. Previous studies have already illustrated that local inflammation is much more
important for early post-operative recovery for a few markers [6], and this study expanded on that
knowledge to provide an extended view of inflammatory cytokines involved in tissue health.
Additionally, spatially dependent responses in cytokine concentrations were observed for IL-1α
and IL-1β when both implant and infection were present, indicating that proximity to infection is
important in the response to PJI. Future work will focus on understanding the upstream and
downstream factors associated with cytokine response in these chronic inflammatory scenarios.

Overall, investigating the localized tissue-level cytokines to understand implant-related
and infection-specific inflammatory complications following knee arthroplasty offered insight into
localized response and the disparities between septic and aseptic inflammation in these surgical
scenarios. Although this study did not control for age, sex, or BMI, these cytokines were not
significantly correlated to these variables, suggesting these were not confounding factors (Table 2)
in this study. Future work will include a larger cohort of patients to control for these factors and
other comorbidities. Ultimately, this study provided a basis to study these cytokines in surgical
scenarios as a quantitative means to understand localized tissue health for debridement.
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Chapter 3
Tissue-Level Cytokines in a Rodent Model of Chronic ImplantAssociated Inflammation and Infection
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3. Tissue-Level Cytokines in a Rodent Model of Implant-Associated Inflammation and
Infection2
Systemic cytokine concentrations have been extensively studied in implant-associated
infections, providing sensitive diagnostic markers. However, less is known about the relationships
of tissue-level cytokines surrounding the joint. The aim of this study was to define the cytokine
profiles of tissues to investigate the use of these cytokines as markers of debridement in chronic
joint infection. Using a rodent model, muscle samples were obtained from rats following Kirschner
wire implantation and infection with Staphylococcus aureus to determine if: 1) differences exist
in cytokine concentrations with proximity to infection, and 2) localized infection-specific markers
can be identified on a tissue level to potentially serve as debridement markers in the future.
Samples were collected from 4 distinct locations, and the concentrations of IL-1α, IL-1β, IL-4, IL5, IL-6, IL-10, IL-12p70, IL-13, GM-CSF, IFN-, and TNF-α were quantified in each sample,
relative to the amount of tissue. Cytokine concentrations differed with proximity to the joint when
implant or infection was present, and tissues at the operative knee joint showed the highest levels
of most cytokines. Additionally, IL-1β, IL-4, and IL-6 showed promise, beyond diagnostics, as
tissue-level indicators of infection response. Ultimately, this study illustrated that tissue-level
evaluation provided insight into infection-specific response, and these markers may be useful for
guiding debridement of implant-associated infections.

2 Parts of this chapter have been published previously from Prince N, Penatzer JA, Shackleford TL, Stewart, EK,
Dietz, MJ, and Boyd, JW. Tissue-Level Cytokines in a Rodent Model of Implant-Associated Infection. Journal of
Orthopaedic Research. 9, 167 (2020). Reproduced with permission from Wiley.
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Introduction
Implant-associated infections are a post-operative complication following total knee
arthroplasty (TKA) procedures, affecting tens of thousands of patients per year in the United States
[1]. Prosthesis-related infections, such as periprosthetic joint infection (PJI), affect the implant and
surrounding tissues, and they can become chronic if bacteria form a biofilm on the prosthesis,
creating a barrier against host response and antibiotic treatment [2]. This pressure on the host’s
immune system combined with antibiotic resistance of the bacteria makes these infections difficult
to reconcile and often results in high failure rates for treatment. Failure rates for all TKA
procedures remain around 5% but are much higher with infected joints, with reported failure rates
ranging from 14-25% [3-5].

Early diagnosis of infection is critical, and a range of sensitive and specific biomarkers,
including C-reactive protein (CRP), alpha-defensin, D-dimer, as well as cytokines like interleukin
(IL)-1β, and IL-6, have been highlighted for their diagnostic utility in implant-associated infections
like PJI [6-9]. Cultures, biopsies, and imaging techniques like PET-MRI and PET-CT have also
been utilized with high sensitivity [10]. Prompt diagnosis can lead to better outcomes in surgical
treatment, and serum biomarkers are most often used to aid diagnostic accuracy [11]. CRP is the
most common diagnostic marker for implant infections, as it is both inexpensive and rapid [12],
however, it suffers from low specificity. CRP levels can be high in a wide range of inflammatory
processes, including the healing process following TKA procedures [13], so a high CRP level
alone cannot positively confirm presence of infection. More recently, diagnostic efforts have
shifted towards the identification and validation of cytokine markers.
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The cytokine response to infection involves both pro- and anti-inflammatory cytokines that
are recruited to the site [14-16]. Due to cytokines’ central roles in infection response, recent studies
have investigated cytokine measurements for their diagnostic utility, especially in infections due
to Staphylococcus aureus, the most common pathogen implicated in implant-associated infections.
Pro-inflammatory cytokines IL-6, IL-1β, and tumor necrosis factor alpha (TNF-α) were first
analyzed in synovial fluid of total hip arthroplasty (THA) patients and showed the ability to
discriminate between aseptic and septic joints [17]. Since then, a variety of other cytokines,
including interferon gamma (IFN-) [18], IL-4 [19], and IL-10 have also been pursued [20].
Frangiamore et al. identified IL-6 and IL-1β not only as markers with excellent diagnostic strength,
but also noted their efficacy for monitoring response to infection treatment in synovial fluid [18].
While these cytokines have shown increased sensitivity and specificity for diagnosis in serum and
synovial fluid, they have not been evaluated to expand their use beyond diagnostics into indicators
of inflammatory immune response to aid treatment.

Surgical debridement is utilized to treat chronic implant infections, but it relies heavily on
subjective assessment of the state of the tissues surrounding the joint [21]. Understanding local
tissue health is important for debridement of infected joints, as surgeons must delineate healthy
from non-healthy tissue to promote infection resolution [22]. Complete removal of infected tissue
is critical, as re-infection only requires a small number of bacteria [23]. Discerning healthy tissue
from infected tissue can be challenging for clinicians, and insufficient debridement is a possible
source for failure of treatment [24]. However, tissues are not intra-operatively analyzed beyond
identification of the “4 C’s”- Color, Consistency, Contractility, and Capacity to bleed- and
quantification of white blood cells. Rarely, the presence or absence of bacteria via culture or
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polymerase chain reaction (PCR) is utilized [17, 25]. Intra-operative assessment of tissues
surrounding the joint for inflammatory cytokine markers could reveal important insights into tissue
health, as these biomarkers are intimately related to infection response [6-8, 26] and wound
resolution [27]. Further, identification of markers to guide debridement would benefit clinical
decision making and allow surgeons to quantitatively assess the state of tissue in infected joints.
Cytokine biomarkers that have previously been utilized for their roles in diagnostics may provide
an avenue to pursue quantitative markers of debridement margins. Defining the tissue-level
concentrations is the first step to evaluating the ability of cytokines as markers of healthy and nonhealthy tissue in chronic implant-associated joint infection.

The purpose of this study was to assess tissue-level cytokine responses in a rodent model
of chronic implant-associated infection, specifically with the purpose of highlighting new
biomarkers of debridement for PJI. Cytokine concentrations were measured in skeletal muscle
samples taken from Sprague-Dawley rats implanted with a Kirschner wire (K-wire) and exposed
to S. aureus in the joint cavity. Levels of pro-inflammatory and anti-inflammatory cytokines were
measured for the following targets: IL-1α, IL-1β, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-13, IFN-γ,
TNF-α, and granulocyte-macrophage colony-stimulating factor (GM-CSF). These factors were
specifically chosen because of their use as diagnostic markers [28], roles in tissue healing [27],
and the ability to give insight into overall tissue health [29]. Ultimately, this study aimed to expand
on the diagnostic roles of these cytokines and investigate them as markers of debridement margins.
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Materials and methods
3.2.1 Animals
All procedures were performed under the guidelines approved by the West Virginia
University Animal Care and Use Committee (Approval #1803013294). Adult male and female
Sprague-Dawley rats (Charles River, Wilmington, MA) were housed individually with a 12:12
light/dark cycle and ad libitum access to standard chow and water. Animals were divided into 3
groups: Sham (N=6), Implant Only (N=6), and Infection+Implant (Inf+Implant; N=6). Animal
numbers for each group were obtained by performing a statistical power analysis using an alpha
value of 0.05 and a difference to detect of 2. The power analysis was based on previous work to
detect trauma-related cytokines, specifically IL-1β [30]. The power analysis necessitated a group
size of N=6 when including both male and female rodents. All procedures were based on previous
models of implant-associated infections in rats with K-wire implant [31-35], and tissues and blood
were collected from all animals 21 days post-surgery.

3.2.2 Experimental rat model of chronic localized infection
Chronic joint infection was established based on literature protocols and previous work.
Briefly, after adequate isoflurane anesthesia, the right leg was shaved and prepared for surgery.
Under sterile conditions, the knee joint was exposed, and a hole was drilled into the medullary
cavity of the femur. For Implant Only and Inf+Implant groups, a 3-cm (male) or 2-cm (female) by
1-mm stainless steel K-wire was implanted into the bone. For Inf+Implant groups, 20 µL of
1.8x107 CFU/mL suspension of Methicillin-sensitive Staphylococcus aureus (MSSA; ATCC
25923, clinical isolate [Manassas, VA]) was injected into the medullary cavity after insertion of
K-wire. This dose was chosen based on previous models to create a chronic localized infection but
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to avoid systemic sepsis [36]. Additionally, a previous study found that inflammation due to
surgery can persist until the 21-day time point, so this time point was chosen for tissue collection
to optimize the measurement of infection-specific inflammatory cytokine responses [36]. Body
temperature was monitored throughout the 21-day time period for presence of fever to ensure no
systemic sepsis occurred. For all groups, the exposed joint was closed with 3-0 vicryl (Ethicon,
Inc., Somerville, NJ) and staples, then Vetbond tissue adhesive (3M, St. Paul, MN) was applied
externally. Buprenorphine SR (ZooPharm, Fort Collins, CO) was administered subcutaneously as
an analgesic providing 72-hour pain relief [37]. Following closure of the knee joint, X-rays were
taken at the 21-day time point and graded according to Aktekin et al [38]. Detailed methods and
results for X-rays can be found in Appendix B.

3.2.3 Tissue collection
At 21-days post-surgery, the animals were again placed under anesthesia, as described
above, and tissue and blood samples were collected. The 21-day post-surgery time point was
chosen for sample collection as it allowed for the local effects in bone and soft tissue [31, 33, 36].
Once samples were collected, the animals were euthanized under isoflurane anesthesia with
cardiac puncture, and one cc of Euthasol (Patterson Veterinary, Greenly, CO) was administered.
Blood was collected in BD Vacutainer SST collection tubes (Becton Dickinson Vacutainer,
Franklin Lakes, NJ), and serum was separated per manufacturer’s instructions. Blood samples
were tested for white blood cell count (WBC) and red blood cell count (RBC) via standard medical
lab testing; CRP (Invitrogen, Carlsbad, CA) and IL-6 levels (Invitrogen) were tested via enzymelinked immunosorbent assay (ELISA) in serum. These systemic measurement parameters can be
found in Table 3.1. For tissue collection, four tissue locations were gently dissected from fascial
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attachments, and skeletal muscle was collected. These locations were chosen to compare tissuelevel cytokines directly at the infected joint to nearby locations to evaluate infection-specific tissue
responses across spatial gradients. Muscle samples were harvested from the following four
locations: at the operative knee joint; 1.5±0.2 cm proximal from operative knee joint; 1.0±0.2 cm
distal from operative knee joint; and from the contralateral leg knee joint. Figure 3.1 illustrates the
sampling locations, labeled as A-D. Tissue samples were cultured to confirm presence or absence
of S. aureus infection at 21 days post-surgery using established methods [39]. Bacterial load at the
operative knee location for the three groups can be found in Table 3.1.

Figure 3. 1. Sampling locations for muscle samples collected at 21 days post-surgery. Immediately
prior to euthanasia, tissue samples were collected by gently dissecting skeletal muscle from fascial
attachments. Four tissue locations were taken, denoted A-D. A) Contralateral leg knee joint; B)
Operative leg, 1.5 cm proximal from knee joint; C) Operative leg knee joint; D) Operative leg,
1.0 distal from knee joint.
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3.2.4 Sample preparation
Samples were washed immediately with 1X cold phosphate-buffered saline (PBS) to
remove blood and debris. Tissues were grossly dissected using a scalpel to remove scar and
connective tissue, then stored at -80ºC. Samples were ground cryogenically and lyophilized for 24
hours. For analysis, lyophilized tissue was thawed for 10 min at 4°C in 1 mL of cell lysis buffer
(Bio-Rad, Hercules, CA) containing 20 mM phenylmethylsulfonyl fluoride (Sigma-Aldrich, St.
Louis, MO). Protein extraction was performed using methods adapted from Hulse et al [40].
Thawed samples were vortexed for 1-3 seconds and centrifuged at 5,000 x g for 5 minutes at 4°C.
The supernatant was collected and tested for total protein content using a Pierce BCA Protein
Assay Kit (Thermo Scientific, Waltham, MA), according to manufacturer’s instructions.
Absorbance values for total protein content were determined on an Infinite M1000 multimode
plate reader (Tecan, Raleigh, NC).

3.2.5 Cytokine and phosphoprotein measurement
To standardize samples for total protein content, tissue homogenates were individually
diluted to a total protein concentration of 900 µg/mL with cell lysis buffer (Bio-Rad). Cytokine
quantification was performed using a magnetic bead-based multiplex Rat Cytokine Th1/Th2 Kit
(Bio-Rad) and measured using a Bio-Plex 200 suspension array system and Pro II Wash Station
(Bio-Rad), according to the manufacturer’s instructions. The Th1/Th2 kit included the following
cytokines: IL-1α, IL-1β, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-13, GM-CSF, IFN-, and TNF-α.
Results for these 11 cytokines were included in this analysis. Additionally, a total of 20
phosphoproteins related to wound healing were tested via custom Bio-Rad multiplex
phosphoprotein ELISA panels. The following targets were assessed, and sites of phosphorylation
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are indicated in parenthesis. CREB (S133), HSP27 (S78), IκB-α (S32/S36), MEK1 (S217/S221),
RPS6 (S235/S236), Smad2 (S165/S167), Src (Y416), Syk (Y352), c-Jun (S63), AKT (S473), p53
(S15), p38 (Y180/Y182), p70S6K (T389), PTEN (S380), ZAP-70 (Y319), BAD (S136), ERK1/2
(T202/Y204 T185/Y187), p90RSK (S380), VEGFR2 (Y1175), and NF-κB p65 (S536).
Phosphoprotein results are discussed following the discussion of cytokines in section 3.4.

3.2.6 Statistical analysis
Data were analyzed using Prism 5 (GraphPad, San Diego, CA) and SAS JMP (Cary, NC).
Standard curves for cytokine concentrations were generated for each protein using either a four(4PL) or five-parameter logistic (5PL) regression model, depending on individual protein.
Cytokine concentrations were determined using standard curve interpolation, then corrected by
dilution factor. To compare cytokines, these values were standardized by tissue weight and
converted to nanograms of cytokine per gram of tissue (ng/g). Implant and Inf+Implant groups
were analyzed with respect to relative fluorescence compared to Sham group. Samples with
fluorescence intensity values below the lower limit of quantitation (LLOQ) or above the upper
limit of quantitation (ULOQ) were omitted from statistical comparisons. Outliers were identified
using the 1.5 X interquartile range (IQR) rule and omitted from analysis. Two-way analysis of
variance (ANOVA) with Bonferroni’s post-test was used to determine significant differences
between Sham (N=6), Implant Only (N=6), and Inf+Implant (N=6) groups as well as between
locations (i.e., in the Sham group, operative knee joint vs. operative leg proximal). Each tissue
homogenate was tested in duplicate for cytokine concentration. Data are expressed as the mean ±
standard error of the mean (SEM).
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Table 3. 1. Clinically-Relevant Parameters at 21 Days Post-Surgery. At 21 days post-surgery,
blood was collected and tested for RBC and WBC; IL-6 and CRP were measured in rat serum.
Additionally, skeletal muscle samples were cultured to calculate bacterial load at the joint. RBC
are shown in scientific notation as million(s) per microliter of blood; similarly, WBC are shown
as thousand(s) per microliter of blood. CRP is shown in milligrams of CRP per liter of serum, and
IL-6 is shown as picograms of protein per milliliter of serum. Bacterial load is shown as colonyforming units (CFUs) per gram of tissue. Significance at p<0.05 is denoted with superscripts “S”
for different than Sham, “C” for different than Implant Only, and “I” for different than Inf+Implant.
Comparisons between groups were identified by one-way ANOVA with Tukey’s post-test. N.D.
is an abbreviation for “not detected.”

SHAM

IMPLANT ONLY

INF+IMPLANT

RBC (x106/µL)

8.14±0.53

7.98±0.54

7.69±0.60

WBC (x103/µL)

3.97±0.78

2.90±2.14

3.63±1.40

CRP (mg/L)

428.51±164.92

620.24±296.11

789.39±181.20

IL-6 (pg/mL)

24.50±0.69C,I

68.18±15.94S

118.06±13.50S

Bacterial load
(CFU/g)*

N.D.

N.D.

1.12x106±6.58x105

*Note: Bacterial load was calculated in tissue cultures, while all other parameters in Table 3.1
were measured in serum.

Cytokine Analysis of Rodent Tissues Between Sham, Implant Only, and Inf+Implant
Groups
Changes in tissue-level cytokine concentrations were observed between Sham, Implant
Only, and Inf+Implant groups in implant-related and infection-specific manners. Overall, cytokine
concentrations were higher for Implant Only and Inf+Implant groups compared to Sham. Intragroup differences between locations were also investigated. Tissues at the operative knee (i.e., the
site of debridement) were compared to all other locations. Cytokine profiles were compared
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between these locations to look for spatially-dependent differences relevant for debridement. The
operative knee and operative leg distal locations generally produced higher cytokine
concentrations than the contralateral knee and operative leg proximal locations. The specific
results are discussed over the following sections and can be seen in Figures 3.2-3.4.

3.3.1 Eight cytokines elevated in implant-related manner
Of the eleven cytokines, eight produced increases in both Implant Only and Inf+Implant
groups compared to Sham (Figure 3.2): IL-1α, IL-5, IL-10, IL-12p70, IL-13, GM-CSF, IFN-, and
TNF-α. These cytokines showed elevated concentrations at the operative knee and operative distal
locations compared to Sham (p<0.05), but there were generally no significant differences between
Implant Only and Inf+Implant groups (exceptions: IL-5 and IL-10 at the operative distal location).
The profiles for Implant Only and Inf+Implant groups across different locations were similar for
all eight of these cytokines. Group-dependent differences at p<0.05 are marked with letters S
(significantly different than Sham group), C (significantly different than Implant Only group), and
I (significantly different than Inf+Implant group). Additionally, all tissue locations were compared
to the operative knee site to understand spatial differences, and significant differences at p<0.05
between locations are marked with striped bars. The average values ± SEM can be found in
Appendix B.
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Figure 3. 2. IL-1α, IL-5, IL-10, IL-12p70, IL-13, GM-CSF, IFN-, and TNF-α concentrations in
response to implant and infection. Concentrations are expressed as nanogram of cytokine per gram
of tissue (ng/g). Statistically significant differences (p<0.05) in protein concentration between
Sham (N=6), Implant Only (N=6), and Inf+Implant (N=6) groups are marked for each location:
“S” represents different than Sham group; “C” denotes different than Implant Only group; “I”
denotes different than Inf+Implant group. All locations were compared to the operative knee site
within each group, and statistically significant differences between locations are marked with
striped bars to indicate difference in concentration compared to the operative knee at p<0.05.
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3.3.2 Three cytokines showed infection-specific response
For three of the eleven cytokines, there was an increase in the Implant Only group, and a
further increase in concentration was observed for the Inf+Implant group. IL-1β, IL-4, and IL-6
showed an infection-specific trend, with the highest concentrations at the operative knee location
(Fig. 3.3). The contralateral knee and operative leg proximal locations were not significantly
different between Sham, Implant Only, and Inf+Implant groups (p>0.05). Group-dependent
differences at p<0.05 are marked with letters S (significantly different than Sham group), C
(significantly different than Implant Only group), and I (significantly different than Inf+Implant
group) in Figure 3.3. Additionally, all tissue locations were compared to the operative knee site,
and significant differences at p<0.05 between locations are marked with striped bars. The average
values ± SEM can be found in Appendix B.
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Figure 3. 3. IL-1β, IL-4, and IL-6 tissue concentrations in response to implant and infection.
Concentrations are expressed as nanogram of cytokine per gram of tissue (ng/g). Statistically
significant differences (p<0.05) in protein concentration between Sham (N=6), Implant Only
(N=6), and Inf+Implant (N=6) groups are marked for each location: “S” represents different than
Sham group; “C” denotes different than Implant Only group; “I” denotes different than
Inf+Implant group. All locations were compared to the operative knee site within each group, and
statistically significant differences between locations are marked with striped bars to indicate the
concentration at that location is different than the operative knee at p<0.05. All labeling is
consistent with Figure 3.2.
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3.3.3 Quadratic discriminant analysis and heat maps of cytokine profiles
Total cytokine profiles were analyzed via QDA with SAS JMP on all measured cytokine
responses at the operative knee location to compare Implant Only and Inf+Implant groups. The
ANOVA data indicated that cytokine profiles were elevated in both of these groups, and QDA
focused on the disparate profiles between Implant Only and Inf+Implant to identify cytokines most
specific for infection on a tissue level. This analysis classified the combined concentrations of all
cytokines observed into pre-determined groups (Implant Only, Inf+Implant) by plotting canonical
scores calculated by the quadratic model. The 95% confidence intervals (CIs) are shown for each
group, with Implant Only in red and Inf+Implant in blue. Biplot rays are shown to denote the
degree of association of each cytokine with each group. There were no misclassifications in the
model. Heat maps were constructed to show relative cytokine concentrations and compare the
influence of cytokines on the cumulative cytokine profile for each group. Cytokine concentrations
in ng/g were normalized between 0 (lowest value) and 1 (highest value) for each cytokine. Green
represents a low relative cytokine concentration, and red represents a high relative cytokine
concentration; the intensity of color denotes the degree of polarization. Relative levels in the Sham
group were in the lowest 10th percentile for all cytokines, which can be observed by the intense
green color. Colors in the Implant Only and Inf+Implant ranged from the 43rd percentile (mild
green-yellow) to 100th percentile (bright red). The heat map results complement the findings of the
QDA by illustrating the contrast in relative concentrations between Implant Only and Inf+Implant
groups for IL-1β, IL-4, IL-6, and IL-12p70.
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Figure 3. 4. QDA analysis (a) and heat map of relative cytokine concentrations (b). QDA analysis
(a) shows the influence of the eleven cytokines on classification into Implant Only (red) or
Inf+Implant (blue) groups. Biplot rays illustrate the degree of association with each group, and
ellipses are drawn to show the mean ± 95% CI for the cumulative cytokine profiles. Heat maps of
relative cytokine concentrations (b) illustrate the relative increases in concentration between the
three groups for direct comparison between cytokines. For heat maps, cytokine concentrations
(ng/g) were normalized between 0 and 1 for each cytokine to show relative increases. Green
represents a low relative concentration, and red represents a high relative concentration.
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Discussion of cytokine concentrations in response to implant and infection
Implant-associated infections like PJI are devastating post-surgical complications and are
the leading cause of implant failure in TKA procedures [1]. Diagnosis and treatment impose a
significant burden for the health care system as well as individual patients, and the annual cost of
infected revisions is projected to exceed $1.5 billion by the end of 2020 [41]. Cytokine
measurements in synovial fluid and serum of patients suffering from chronic PJI have illustrated
high sensitivity and specificity of these targets for diagnostic purposes [20]. However, the primary
method for treatment of chronic, recurrent implant-associated infections is debridement, which has
highly subjective endpoints [21]. Treatment has not progressed to more objective metrics,
presenting a challenge for clinicians who are tasked with precise, complete removal of infected
tissues. Cytokine biomarkers currently used for diagnostics may provide potential for use as
quantitative markers for establishing intra-operative debridement margins between healthy and
non-healthy tissue. In this study, eleven cytokines were analyzed in a rodent model of chronic
implant-associated infection to identify biomarkers that have the potential to delineate infected vs.
non-infected tissues. Ultimately, these cytokines could aid clinicians in establishing debridement
margins using reliable, quantitative metrics.

Eight cytokines exhibited implant-related increases in concentration at the operative knee:
IL-1α, IL-5, IL-10, IL-12p70, IL-13, GM-CSF, IFN-, and TNF-α (Fig. 3.2). For these cytokines,
Implant Only and Inf+Implant groups showed higher concentrations than the Sham group (p<0.05),
but there were no significant differences between Implant Only and Inf+Implant groups directly
at the operative knee. These cytokines have previously been linked to inflammation associated
with prosthetics [42], and our results indicated that inflammation at the joint can be attributed to
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the presence of a K-wire implant (Fig. 3.2). All of these cytokines gave the highest response
directly at the operative knee location, with the exception of IL-1α for the Inf+Implant group,
which had an unclear trend. Decreased cytokine profiles would suggest a return to healthy tissue
[29], which is relevant to debridement, so all tissue locations were compared to the operative knee
to investigate the spatially-disparate responses. IL-1α, IFN-, and TNF-α did not show the ability
to reliably discriminate tissues across locations, and previous studies have noted low specificity in
serum for these cytokines in implant-associated infections [43]. The ANOVA data in this study
suggested they would not be reliable debridement markers (Fig. 3.2). Disparities between operative
knee and operative distal sites for the Inf+Implant group were observed for IL-5, IL-10, IL-13, and
IL-12p70, but these differences were not present in the Implant Only group. The Implant Only
group still maintained elevated IL-5, IL-10, and IL-13 concentrations at the operative distal site
(Fig. 3.2; p<0.05), but the Inf+Implant group showed a decrease at this location. These are three
anti-inflammatory cytokines [44], and they all showed elevation at tissues downstream of the joint
in the Implant Only group. IL-12p70 also appeared to follow this trend, but not at a statistically
significant level (Fig. 3.2; p>0.05). IL-12p70 is an immunoregulatory cytokine with both pro- and
anti-inflammatory functions and plays a role in cell proliferation during wound healing [45]. The
exact mechanisms of cytokine dysregulation due to implant and infection are unknown, but the
spatially disparate downstream effects observed for these cytokines could be due to a variety of
factors, including vascular supply [46], atrophy [35], or differences in wound healing stages [47].
While outside the scope of this manuscript, the spatially disparate profiles of these cytokines due
to foreign body implant warrant future investigation. GM-CSF was the only implant-related
cytokine to show the expected spatially-dependent trend for both the Implant Only and Inf+Implant
groups (Fig. 3.2; p<0.05). GM-CSF has been noted for its role in inflammatory autoimmune
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diseases and has shown increased concentrations in response to pro-inflammatory stimuli [48].
However, the QDA illustrated it was not a good differentiator of inflammation due to implants vs.
inflammation due to infection (Fig. 3.4). Overall, the data in this study indicated that none of the
implant-related cytokines were good indicators of debridement margins at the operative knee.

Infection-specific trends in cytokine responses were present for IL-1β, IL-4, and IL-6 in
this study (p<0.05). These cytokines have been noted for their roles in infection, demonstrating
increases in serum concentrations in response to joint infection [49-51]. In this study, these
cytokines showed the highest increase in response directly at the operative knee (Fig. 3.3),
highlighting the importance of tissue-level disparities in response to infection. IL-1β and IL-6, two
pro-inflammatory cytokines, have demonstrated diagnostic utility and were elevated in response
to infection in this study [52]. Infection with S. aureus is known to trigger IL-1β release and is
concomitant with cell death [53]. IL-6 is synthesized in infectious lesions to send out a warning
signal of tissue damage, which is then recognized by pathogen-recognition receptors (PRRs), and
it is an early initiator of infection-related inflammation [54]. Both IL-1β and IL-6 produce signals
during infection that ultimately trigger cell death pathways [55]. For IL-1β, all locations were
significantly different than the operative knee (p<0.05) for both Implant Only and Inf+Implant
groups (Fig. 3.3). IL-6 only reflected this trend in the Inf+Implant group, but the increased
concentrations at the operative knee location compared to Implant Only suggested it is still a good
indicator of infection presence (p<0.05, Fig. 3.3). IL-4, an anti-inflammatory cytokine, activates
the Stat6 pathway in infection and suppresses cell-mediated death [56]. IL-4 trends were similar
to IL-6, and only the Inf+Implant group showed a significant decrease in concentration at the
operative distal location (p<0.05). QDA and heat maps were constructed to comparatively assess
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the contributions of these cytokines to each of the groups. The heat maps showed relative
concentrations of cytokines and suggested IL-1β, IL-4, and IL-6 may all serve as good indicators
of infected tissues at the joint. Further analysis of QDA data indicated IL-1β and IL-6 are strongly
indicative of Inf+Implant tissues (Fig. 3.4), while IL-4 plays a role in both Implant Only and
Inf+Implant groups when considering total cytokine contributions. The QDA demonstrated that
IL-1β and IL-6 show a stronger relationship to Inf+Implant tissues and may serve as better
indicators for debridement.

The results of this study demonstrated that tissue-level concentrations of IL-1β and IL-6
are strongly indicative of infected tissues through ANOVA comparisons as well as QDA
classifications. These cytokines have previously been validated for diagnostics of implantassociated infections in serum, and they have established roles in infection response. The findings
presented here offer an opportunity to expand their utility beyond diagnostics as tissue-level
indicators of infection. These results provided evidence that these cytokines are worth pursuing in
the development of objective biomarkers to guide debridement and treatment of chronic implantassociated infections. Ultimately, this study laid the foundation to develop quantitative, tissuelevel biomarkers to aid surgical decision making. In the future, these cytokines could be
investigated for their ability to guide intra-operative debridement.
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Phosphoprotein and Ingenuity Pathway Analysis (IPA) to understand spatiallydisparate responses
The cytokine analysis in this study provided important insights into the tissue-level immune
response to chronic infection and highlighted biomarkers that could be used for debridement of
chronically infected tissues, but the analysis also provoked questions regarding the responses of
tissues upstream and downstream of the operative site. The initial cytokine study primarily
addressed the response directly at the operative knee, as this is the most relevant for surgical
debridement, but the responses of proximal and distal tissues also showed altered concentrations
of some cytokines. Increases in all cytokines, either due to implant or infection, suggested some
disruption of normal inflammatory immune response (Figs. 3.2 and 3.3), and evidence suggests
that excessive inflammation caused by these cytokines can delay wound healing [62]. Elevated
cytokine levels at proximal or distal locations could suggest that healing processes in these tissues
are compromised, so wound healing phosphoproteins were also assayed to investigate the
responses proximal and distal to the operative knee.

GM-CSF, IL-4, and IL-1β all showed the expected trend with elevation at the operative knee,
and other locations in the Implant Only and Inf+Implant groups were statistically significantly
different from the operative knee at p<0.05 (with one exception: IL-4 in the Implant Only group
operative knee vs. operative distal, but it appeared to follow the trend; Figs. 3.2 and 3.3). However,
the other cytokines showed elevated cytokine concentrations either at the op prox or op dist
locations. Four cytokines, IL-5, IL-10, IL-12p70, and IL-13 showed elevated levels in response to
implant, and the operative distal location maintained higher concentrations of these cytokines (Fig.
3.2). While IL-6, one of the infection-specific cytokines, showed significant differences between
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locations in the Inf+Implant group (p<0.05), the Implant Only group did not show any significant
differences between locations. Other cytokines, IL-1α, IFN-γ, TNF-α showed less spatial disparity
and did not inform differential wound healing responses between locations. All of these cytokines
have established roles in acute infection response [6-9, 14-16, 18-20], but chronic infections can
disrupt cell signaling networks associated with these responses [63, 64]. The inflammation due to
foreign body implant, infection, or both may be negatively impacting the ability of tissues to heal,
but cytokines alone are not enough to understand these wound healing cascades.

To investigate the networks of tissue healing between disparate locations, phosphoprotein
analysis was conducted as a follow-up to the cytokine work. Network analysis can give
information about the connectivity of wound healing signaling and highlight key mediators of the
response [65, 66]. QIAGEN’s Ingenuity Pathway Analysis (IPA) software application is a
commonly used tool for creating and analyzing complex biological networks. This method uses
both experimental and literature-derived data to connect different targets, referred to as “nodes,”
resulting in a model of response. IPA utilizes the Ingenuity Knowledge Base, a repository derived
and curated from previous studies, to identify highly interconnected “Focus Genes” and construct
a network [67]. Top molecular and cellular function associated with the networks are also reported
by IPA, which allows researchers to further probe into which cellular processes may be activated
and which nodes are most important in the network.
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Methods for phosphoprotein and network analysis
3.6.1 Statistical analysis of phosphoproteins
Phosphoprotein data was acquired using multiplexed magnetic bead-based assays (BioRad) and measured using a Bio-Plex 200 suspension array system (Bio-Rad), as described in
section 3.2.5. Data were analyzed using Prism 5 (GraphPad, San Diego, CA), and relative
phosphorylation levels were calculated from fluorescence intensity values. Differences between
groups and tissue locations were compared based on relative phosphorylation in samples
standardized to a total protein concentration of 900 µg/mL. Samples with fluorescence intensity
values below the lower limit of quantitation (LLOQ) or above the upper limit of quantitation
(ULOQ) were omitted from statistical comparisons. Outliers were identified using the 1.5
X interquartile range (IQR) rule and removed. Two-way analysis of variance (ANOVA) with
Bonferroni’s post-test was used to determine significant differences between Sham (N=6), Implant
Only (N=6), and Inf+Implant (N=6) groups as well as between locations (i.e., in the Sham group,
operative knee joint vs. operative leg proximal). Each tissue homogenate was tested in duplicate.
Data are expressed as the mean ± standard error of the mean (SEM). ANOVAs are shown for 16
out of the total 20 phosphoproteins tested. Five phosphoproteins, HSP27 (S78), Src (Y416), p53
(S15), ZAP-70 (Y319), and NF-κB p65 (S536), did not produce statistically significant trends (data
not shown).

3.6.2 Construction of IPA networks
Both cytokines and phosphoproteins were included in the creation of IPA networks, and all
31 targets were included (11 cytokines and 20 phosphoproteins), regardless of whether or not they
produced statistically significant ANOVA comparisons between groups or locations at p<0.05.
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IPA uses the relative up- and down-regulation of targets compared to a control to construct
networks, so all 31 targets were normalized by correcting the concentration/relative
phosphorylation values at each location to the contralateral leg for every individual animal. This
method allowed for correction arising from biological variability and provided some correction for
systemic inflammation. These normalized responses were investigated with QIAGEN’s
Ingenuity® Pathway Analysis (IPA®, QIAGEN, Redwood City), and proposed networks were
created for each group (Sham, Implant Only, Inf+Implant) at each of the three locations (Op Prox,
Op Knee, Op Dist). The IPA networks consist of nodes from the experimental dataset and
literature-derived projected nodes likely to be involved, identified by Ingenuity Knowledge Base.
Up- and down-regulated responses are color coded using red and green, respectively. IPA also
reported top up- and down-regulated targets for each of the nine networks, based on changes in
expression across groups.

Results of phosphoprotein data and IPA networks
3.7.1 Ten phosphoproteins were elevated in response to implant or infection
Phosphoprotein levels were compared between groups and locations, and ten of the twenty
phosphoproteins tested exhibited increased phosphorylation levels when implant or infection was
present: MEK1 (S217/S221), RPS6 (S235/S236), p70S6K (T389), PTEN (S380), BAD (S136),
p90RSK (S380), VEGFR2 (Y1175), ERK1/2 (T202/Y204 T185/Y187), IκB-α (S32/S36), and cJun (S63). Trends between the three groups are specifically discussed in the following paragraphs.
MEK1, RPS6, p70S6K, PTEN, BAD, p90RSK, VEGFR2, and IκB-α showed increases in
both Implant Only and Inf+Implant groups compared to Sham at a statistically significant level
(p<0.05) at a minimum of one tissue location. ERK1/2 also appeared to follow this trend, but it
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did not produce statistically different phosphorylation levels compared to the Sham group (Fig.
3.5). Additionally, some of these cytokines produced significant comparisons between the Implant
Only and Inf+Implant groups at p<0.05 at certain tissue locations. p70S6K and BAD showed
differences between Implant Only and Inf+Implant proximal to the operative site (p<0.05), and
p90RSK was significantly higher in Inf+Implant compared to Sham and Implant Only directly at
the operative site (Fig. 3.5, p<0.05). c-Jun did not show as much of a disparity in relative
phosphorylation levels between the three groups compared to the other targets tested, with the only
significant comparison at p<0.05 being Inf+Implant at the operative knee compared to both Sham
and Implant Only at this location (Fig. 3.5).
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Figure 3. 5. Ten phosphoproteins showed elevated levels in response to implant and infection.
Relative phosphorylation levels were compared between all samples at a concentration of
900 µg/mL total protein. Statistically significant differences (p<0.05) in relative phosphorylation
between Sham (N=6), Implant Only (N=6), and Inf+Implant (N=6) groups are marked for each
location: “S” represents different than Sham group; “C” denotes different than Implant Only group;
“I” denotes different than Inf+Implant group. All locations were compared to the operative knee
site within each group, and statistically significant differences between locations are marked with
striped bars to indicate the concentration at that location is different than the operative knee at
p<0.05.
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3.7.2 Five phosphoproteins showed increased responses proximal or distal to the
operative knee
Of the twenty phosphoproteins tested, five showed trends of increased phosphorylation levels
proximal or distal to the operative knee in either the Implant Only group, Inf+Implant group, or
both. CREB (S133), Smad2 (S165/S167), and Syk (Y352) showed phosphorylation levels at the
operative distal site that were significantly higher than the Implant Only or Sham groups (p<0.05).
For all three of these targets, the operative distal location was not significantly different at p<0.05
from the operative knee site within the Inf+Implant group. In other words, phosphorylation of
CREB, Smad2, and Syk in the Inf+Implant group was similar between these two locations and
significantly higher (p<0.05) than the other two groups.

Phosphorylation levels of AKT (S473) and p38 (Y180/Y182) trended upward in both the
Implant Only and Inf+Implant groups and were higher than levels in the Sham group (Fig. 3.6).
Phosphorylated p38 was significantly higher at the operative distal site than the operative knee in
the Inf+Implant group (p<0.05); the Implant Only group only exhibited an increase, but it was not
at a statistically significant level. Additionally, both AKT and p38 were present at significantly
higher levels in the operative proximal tissues compared to operative knee in the Implant Only
group. However, this was not the case for the Inf+Implant group (Fig. 3.6).
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Figure 3. 6. Five phosphoproteins showed elevated levels proximal or distal to the opeartive knee
site. Relative phosphorylation levels were compared between all samples at a concentration of
900 µg/mL total protein. Statistically significant differences (p<0.05) in relative phosphorylation
between Sham (N=6), Implant Only (N=6), and Inf+Implant (N=6) groups are marked for each
location: “S” represents different than Sham group; “C” denotes different than Implant Only group;
“I” denotes different than Inf+Implant group. All locations were compared to the operative knee
site within each group, and statistically significant differences between locations are marked with
striped bars to indicate the concentration at that location is different than the operative knee at
p<0.05.
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3.7.3 IPA revealed differences in wound healing responses
IPA was used to construct network of responses for all nine networks (3 groups, 3 tissue
locations) from experimentally-derived and literature-derived data (Fig. 3.7). A qualitative
analysis of connectivity of the networks was conducted by quantifying the number of edges in
each individual network. An “edge” is a connection between two nodes, and IPA draws edges
between nodes by quantifying the overlap via a Fisher’s Exact Test with significance set to p<0.01.
A higher number of edges in a network signifies greater connectivity, since there are more
relationships between sets of nodes. In this study, the following number of edges were identified
in each network (with number of edges shown in parenthesis after the network name): Op Prox
Sham (101), Op Knee Sham (99), Op Dist Sham (101), Op Prox Implant Only (98), Op Knee
Implant Only (104), Op Dist Implant Only (99), Op Prox Inf+Implant (99), Op Knee Inf+Implant
(99), Op Dist Inf+Implant (96). The average number of edges was 99.6, so all networks were
within 5 edges of the average.

While the connectivity was similar between all nine networks, construction (i.e., the position
of nodes) differed. An analysis of important up- and down-regulated targets was conducted to
better understand which nodes may differ between the networks. Changes in expression were
compared, with a positive change signifying up-regulation and a negative change denoting downregulation. The top three nodes for up- and down-regulation from the experimental data set were
identified at the operative knee joint, and the behavior of these nodes is graphed between all three
locations to show a comparison between Op Prox, Op Knee, and Op Dist (Fig. 3.8).
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Figure 3. 7. Ingenuity Pathway Analysis (IPA)-generated networks. Proposed networks used
relative cytokine and phosphoprotein responses. Nodes are illustrated in a “heat map” coloring
scheme, with red denoting up-regulation, green denoting down-regulation, and the intensity of
color correlates to the intensity of relative response. The networks are supplemented with other
nodes likely to be involved, as identified in the Ingenuity Knowledge Base. A solid line represents
a direct interaction between two nodes, while a dotted line denotes an indirect relationship.
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Figure 3. 8. Comparison of top up- and down-regulated nodes compared to the operative knee.
Differences in expression for the top three up-regulated and down-regulated nodes from the
experimental data set are shown for each of the three groups. The average expression change ±
SEM is shown for each node.
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Discussion of Wound Healing Network Analysis
Network analysis provided some clarity on the aspects of tissues upstream and downstream
from the operative knee that may affect immune response at operative knee location. It is well
established that the cytokines investigated in this study play important roles in the inflammatory
response to implants or infection [2], and to better understand the impacts on cell signaling related
to wound healing, phosphoproteins were included in a follow-up analysis. These phosphoproteins
are related to wound healing processes such as proliferation [68-70], fibrosis and establishment of
connective tissue [71-73], and inflammatory apoptosis [74-76]. Changes in expression levels of
these targets between locations may highlight some of the disruptions observed for cytokines at
the operative proximal or operative distal sites.

While the overall connectivity of networks of cytokines and phosphoproteins analyzed by
IPA was similar based on the number of edges, the construction differed as well as the up- and
down-expression of nodes. Top contributors were identified in each of the nine networks by
highlighting the top three up-regulated and down-regulated nodes. Changes between tissue
locations for these top network contributors may indicate targets that highly influence the response
[77]. Within the Sham group, comparison of the top up- and down-regulated targets between
locations revealed that phosphoproteins p70S6K and ERK1/2 were higher at proximal and distal
locations compared to the operative knee (p<0.05), and both of these phosphoproteins are
important for proliferative processes in wound healing [70]. Cytokine IL-5 expressed higher
directly at the joint than the proximal location (p<0.05) but was not significantly different than the
distal location (Fig. 3.8). IL-5 is a mediator of TH2 immunity and promotes eosinophil-mediated
inflammation [78], so its elevation at the operative knee and operative distal locations may signify
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that there is a higher degree of inflammation at these locations, which agrees with the cytokine
data as a whole (Figs. 3.2 and 3.3). In the Implant Only group, pro-inflammatory IL-1β was
significantly lower at the proximal and distal locations compared to the operative knee (p<0.05),
and IL-12p70 showed the same trend at the proximal tissue (p<0.05), suggesting that a potent proinflammatory response is present at the operative knee in response to implants. Three
phosphoproteins, MEK1, p38, and p53 were all significantly higher at both the proximal and distal
locations compared to the operative knee (p<0.05). These phosphoproteins are important for
wound healing during multiple stages, including proliferation [69], migration [74], and apoptotic
processes in wound healing [71]. Following the same trend at the Sham group, the Implant Only
group showed higher cytokine expression at the operative knee and lower levels of wound healing
phosphoproteins. In the Inf+Implant group, pro-inflammatory IL-1β was significantly higher at
the operative knee than proximal and distal to this site (p<0.05), and TNF-α was lower in proximal
tissues (p<0.05). Phosphoprotein p38 was expressed in higher levels at the operative distal location
compared to the joint site (p<0.05).

There were several limitations to this study. The cytokine concentrations were measured
in rodents that were treated with anesthetics and analgesics. Many studies have observed
suppression of cytokine production following administration of these agents [57, 58]. The use of
isoflurane and buprenorphine was specifically chosen to avoid significant modulation of cytokine
response [37]. Buprenorphine has been shown to have no significant effect on cytokine production
in rodents [59]. While isoflurane has been shown to increase levels of pro-inflammatory cytokines
like IL-1β, IL-6, and TNF-α [60], comparison with the Sham group still illustrated an increase in
levels of these cytokines due to both implants and infection. Many approaches to studying chronic
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joint infections like PJI have been pursued in literature [61], and this study represents only one
infecting organism, S. aureus, at one post-surgical time point in a non-load bearing K-wire implant
model. Future studies will focus on varying durations of infection, include other infecting
organisms, and multiple inoculation doses.

In conclusion, the follow-up network analysis provided some insight into the spatiallydependent tissue response, which may have implications healing. When comparing the operative
proximal and operative distal locations to the operative knee, phosphoproteins identified in IPA as
top contributors- p70S6K, ERK1/2, MEK1, p38, and p53- were consistently higher at proximal
and distal sites (Fig. 3.8). Cytokines IL-5, IL-1b, IL-12p70, and TNF-α were also identified as top
contributors in IPA, and these were consistently higher at the operative knee. Further, IL-5, IL12p70, and TNF-α were significantly lower proximal to the joint in the Sham, Implant Only, and
Inf+Implant groups, respectively, suggesting that the distal location may maintain a higher degree
of inflammation similar to the operative site. The network analysis allowed identification of likely
contributors to differences in healing responses, and these results suggested that cytokines
dominate the healing response at the operative knee in all three groups, while wound healingrelated phosphoproteins govern the response at proximal and distal sites.
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Chapter 4
Impact of Cytokines and Phosphoproteins in Response to Chronic Joint
Infection
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4. Impact of Cytokines and Phosphoproteins in Response to Chronic Joint Infection 3
The early cellular response to infection has been investigated extensively, generating
valuable information regarding the mediators of acute infection response. Various cytokines have
been highlighted for their critical roles, and the actions of these cytokines are related to intracellular
phosphorylation changes to promote infection resolution. However, the development of chronic
infections has not been thoroughly investigated. While it is known that wound healing processes
are disrupted, the interactions of cytokines and phosphoproteins that contribute to this
dysregulation are not well understood. To investigate these relationships, this study used a network
centrality approach to assess the impact of individual cytokines and phosphoproteins during
chronic inflammation and infection. Tissues were taken from patients undergoing total knee
arthroplasty (TKA) and total knee revision (TKR) procedures across two tissue depths to
understand which proteins are contributing most to the dysregulation observed at the joint. Notably,
p-c-Jun, p-CREB, p-BAD, IL-10, IL-12p70, IL-13, and IFN-γ contributed highly to the network
of proteins involved in aseptic inflammation caused by implants. Similarly, p-PTEN, IL-4, IL-10,
IL-13, IFN-γ, and TNF-α appear to be central to signaling disruptions observed in septic joints.
Ultimately, the network centrality approach provided insight into the altered tissue responses
observed in chronic inflammation and infection.

3 Parts of this chapter have been published previously from Prince N, Penatzer JA, Dietz, MJ, and Boyd, JW. Impact
of Cytokines and Phosphoproteins in Response to Chronic Joint Infection. Biology. 9, 167 (2020).
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Introduction
Acute responses to inflammation and infection have been well studied in literature, and
these studies have highlighted important roles for many cytokines [1–3] and phosphoproteins [4,5]
in early inflammatory immune processes. The coordinated series of signaling events involves the
recruitment of pro-inflammatory regulators like IL-1α, IL-1β, and IL-6 [6–8] to the site, provoking
intracellular phosphorylation changes of many mitogen-activated protein kinase (MAPK/ERK)
mediators [9–11]. This acute inflammatory response to infection is predictable. However, less is
known about the transition that leads to the development of chronic infections [12]. Chronic,
persistent infections are challenging to treat and can present a challenge for clinicians [13].
Periprosthetic joint infection (PJI) is an infection surrounding a prosthetic knee and represents one
example of localized infections that can transition into a chronic state. Dysregulation of immune
mediators has been observed systemically for PJI [14,15], but the mechanisms that lead to these
signaling disruptions have not been investigated [16]. PJI affects approximately 40,000 patients
per year in the United States [17], and resolving these chronic infections is a high priority for
clinicians. These patients suffer from chronic inflammation surrounding the joint due to presence
of implant as well as infection [18,19]. This compound inflammation makes the tissue-level
response difficult to understand using traditional statistical approaches. Further investigation into
the tissue-level disruptions that lead to chronic infection and inflammation may allow a better
understanding of how best to address these conditions.

Network analysis approaches allow for a global evaluation of these complex, tissue-level
disruptions [20]. Traditional statistical methods for evaluating these contributions may be limited,
as they can only evaluate one component individually. Conversely, network analysis approaches
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allow for an understanding of the interactions of different components with respect to the entire
signaling network [20]. Currently, pathway analysis software like Ingenuity Pathway Analysis
(IPA), Cytoscape, and iPathway Guide are used to analyze these types of datasets from a network
perspective, and these tools offer an enriched understanding of biological networks. These
applications allow users to construct networks, analyze molecular functions, and identify disease
states using experimental and literature-derived data [21,22].

Beyond literature-based enrichment of data, mathematical modeling, such as network
centrality parameter analysis, can be used to dissect large datasets and understand relationships
between the individual components. Network centrality parameters assign quantitative values to
every measured target (node) to describe how central each target is relative to all other nodes in
the network. Some examples of centrality parameters are degree (number of direct neighbors),
diameter (maximum distance between nodes in the network), and radiality (shortest path between
a node and all other nodes, normalized to network diameter) [23].

A node with a high radiality indicates that node is central to the network, and networks
with mostly high radiality nodes are behaving in an organized manner. Conversely, nodes with
low centrality values have peripheral roles, and networks with many low radiality nodes may be
interpreted as an open cluster of proteins that are connecting to other regulatory molecules [23].
By focusing on the nodes with low centrality outcomes, it may be possible to understand which
peripheral nodes are contributing to the dysregulation observed in networks of chronic
inflammation and infection that occur in TKR patients, especially those suffering from PJI.
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Radiality has been used in literature to probe biological networks and garner information about
protein-protein interactions to understand chronic inflammatory conditions like diabetes [24],
cancer [25], and chronic viral infections [26]. Ultimately, using radiality to evaluate these signaling
networks allowed an opportunity to identify new therapeutic targets to combat these conditions.
Evaluating the nodes that are most central and most peripheral in chronic infections like PJI may
yield similar benefits.

In this study, nine cytokines and twenty-one phosphoproteins were measured in tissues
surrounding the knee joint to evaluate differences between native response in primary TKA,
chronic inflammatory response in aseptic TKR, and chronic infection response in septic TKR. Two
tissue depths were evaluated for each group: adjacent tissue layer (ATL), unhealthy tissue that is
close to the joint and requires removal; and radial tissue layer (RTL), healthy tissue that does not
need to be removed. The dataset was examined using IPA and network centrality radiality to allow
both qualitative and quantitative evaluations of cytokine and phosphoprotein contributions. A
comparison of radiality values between primary TKA, aseptic TKR, and septic TKR allowed for
a narrowing of the nodes with particularly distinct responses. These nodes may have important
contributions to the disruption of normal cell signaling events. In the future, a focused analysis of
these protein targets may facilitate the development of new therapeutics to combat persistent
inflammation and infection observed in these patients.
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Materials and methods
4.2.1 Patient cohort
All subjects gave informed consent for inclusion in the study, and the study was conducted
in accordance with the Declaration of Helsinki. Following Institutional Review Board (IRB)
approval (IRB protocol #1709745853) and patient consent, six patients undergoing primary total
knee arthroplasty (TKA) and eleven patients undergoing total knee revision (TKR) procedures
participated in the study (8 males and 9 females; aged 45–82 years; body max index [BMI] 24.6–
43.7; information can be found in Table 4.1), and subjects were recruited over a 12-month period.
All six primary TKA patients were undergoing elective surgery for total replacement of the knee
joint with a diagnosis of osteoarthritis. In the TKR group, patients were further characterized into
aseptic and septic revision procedures. Patients with aseptic revisions (N = 5) were undergoing
revisions due to failures of the prosthetic joint but did not show presence of infection. Patients with
septic revisions (N = 6) met clinical criteria for a PJI diagnosis, as defined by the Musculoskeletal
Infection Society (MSIS) criteria [27]. All six patients diagnosed with PJI had positive tissue
cultures on the day of surgery: four tested culture positive for Staphylococcus epidermidis, one for
Methicillin-sensitive Staphylococcus aureus (MSSA), and one for Enterobacter cloacae. All
groups of patients received the same pre-operative pain relief and anesthesia, per standard clinical
procedures.
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Table 4. 1. Patient Information. Six primary TKA and eleven revision TKR patients were enrolled
in the study, creating a heterogenous cohort of males and females varying in age (45-82 years) and
comorbidities. Primary TKA patients have ID format P#; revision TKR patients have ID format
F#. This table lists general patient information including the pathogen for which each septic patient
tested culture-positive following testing on the day of surgery. Serum CRP values were obtained
pre-operatively in the revision setting. Cultures were obtained from intraoperative tissue samples.

ID

Sex

TKA/TKR

BMI(kg/m2)

Diabetic (Y/N)

CRP (mg/L)

Culture

P1

F

TKA

33.8

N

N/A

Negative

P2

F

TKA

39.8

N

N/A

Negative

P3

F

TKA

39.8

N

N/A

Negative

P4

M

TKA

29.7

Y

N/A

Negative

P5

M

TKA

24.6

N

N/A

Negative

P6

M

TKA

27.2

N

N/A

Negative

F1

F

TKR- Aseptic

28.2

N

4.3

Negative

F2

F

TKR- Aseptic

29.8

N

0.2

Negative

F3

F

TKR- Aseptic

33.9

N

<1

Negative

F4

M

TKR- Aseptic

40.4

Y

3.6

Negative

F5

M

TKR- Aseptic

26.2

N

2.1

Negative

F6

F

TKR- Septic

43.7

N

28.8

S. epidermidis

F7

F

TKR- Septic

30.8

Y

161.4

S. epidermidis

F8

F

TKR- Septic

41.9

N

21.7

E. cloaecae

F9

M

TKR- Septic

36.2

N

33.5

MSSA

F10

M

TKR- Septic

33.8

Y

3.8

S. epidermidis

F11

M

TKR- Septic

31.9

N

111.9

S. epidermidis

123

4.2.2 Collection of tissue samples
All TKA and TKR procedures were performed by a single surgeon with standard
debridement and washing protocols. Debridement during TKA and TKR is the removal of
unhealthy tissue surrounding the joint [28]. Tissues were collected at a total of four distinct
anatomical locations, shown in Figure 4.1. The solid line circle represents location 1: medial
femoral condyle (F); the dashed line circle represents location 2: medial tibial plateau (T); the solid
line square represents location 3: lateral gutter (LG); and the dashed line square represents location
4: posterior capsule (PC). These tissues were collected at two tissue layers, the adjacent tissue
layer (ATL) and radial tissue layer (RTL). The ATL samples came from the initial debridement;
these tissues are removed during surgery to promote better wound healing. RTL samples were
taken from a tissue layer further removed from the joint after the surgeon completed debridement.
The difference in depth of the RTL tissues and ATL tissues was ~1 cm. Anatomical locations 1–4
were collected for the ATL layer, and locations 1–3 were collected for the RTL layer. Location 4
(PC) could not be taken in the RTL layer due to proximity to neurovascular structures. Therefore,
a total of seven tissue samples were taken for each patient.
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Figure 4. 1. Map of approximate tissue collection locations, shown with prosthetic implant.
Seven tissue samples were taken for each patient; (1) the solid circle represents the medial
femoral condyle (denoted as F); (2) the dashed circle represents the medial tibial plateau
(denoted as T); (3) the solid square represents the lateral gutter (denoted as LG); (4) the dashed
square represents the posterior capsule (denoted as PC). Locations 1–4 were taken for the ATL
layer, and locations 1–3 were taken for the RTL layer; separation between ATL (unhealthy
tissue, closer to joint) and RTL (healthy tissue, further from joint) was approximately 1 cm,
depending on individual patient.

4.2.3 Sample preparation
Tissues were collected during TKA and TKR procedures in the operating room and
immediately stored on dry ice. Once all tissues had been collected for an individual patient, they
were washed with 1X cold phosphate-buffered saline (PBS) to remove blood and debris. Tissues
were grossly dissected using a scalpel to remove scar tissue, then stored at −80 °C. When samples
had been collected for all patients, tissues were thawed on ice and cut into sections approximately
30 mg in size; tissues were homogenized by sonication in 500 µL cell lysis solution (Bio-Rad,
Hercules, CA) containing 20 mM phenylmethylsulfonyl fluoride (Sigma-Aldrich, St. Louis, MO).
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Protein extraction was performed using methods adapted from Hulse et al. [29]. Thawed samples
were vortexed for 1–3 s and centrifuged at 5000× g for 5 min at 4 °C. The supernatant was collected
and tested for total protein content using a Pierce BCA Protein Assay Kit (Thermo Scientific,
Waltham, MA), according to the manufacturer’s instructions. Absorbance values for total protein
content were determined on an Infinite M1000 multimode plate reader (Tecan, Raleigh, NC).

4.2.4 Cytokine and phosphoprotein measurement
To standardize samples for total protein content, tissue homogenates were individually
diluted to a total protein concentration of 900 µg/mL with cell lysis buffer (Bio-Rad). Cytokine
and phosphoprotein measurements were performed using magnetic bead-based multiplex
Inflammation Human ProcartaPlex panel assays (Invitrogen, Carlsbad, CA) and custom Bio-Plex
human phosphoprotein multiplex kits. Targets were measured using a Bio-Plex 200 suspension
array system and Pro II Wash Station (Bio-Rad), according to the manufacturer’s instructions. All
cytokines and phosphoproteins measured in the study are listed in Tables 4.2 and 4.3 along with
references for their roles in tissue healing.
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Table 4. 2. Cytokine Targets Measured in Tissue Samples. All cytokines measured in this study
are listed along with relevant functions during wound healing. Citations are noted in brackets.
Cytokine
IL-1β
IL-4
IL-6
IL-1α
IL-10
IL12p70
IL-13
IFN-γ
TNF-α

Relevant Functions in Acute Wound Healing Response
Early initiator of infection-driven inflammation [2]
Anti-inflammatory cytokine that activates Stat6, suppressing cell death [42]
Initiator of early inflammatory response to implants and infection [2]
Early recruitment of immune cells in response to infection [2]
Down-regulator of several inflammatory cytokines (i.e., IL-1, IL-6, IL-12, IFN-γ,
TNF-α) [43]
Pro-inflammatory cytokine involved in adaptive immunity, produced by activated
immune cells [43]
Th2-associated cytokine critical in tissue remodeling [44]
Anti-inflammatory cytokine that has been associated with inhibition of wound
healing [43]
Early pro-inflammatory mediator of inflammation [2]
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Table 4. 3. Phosphoprotein Targets Measured in Tissue Samples. All phosphoproteins measured
in this study are listed as well as the site of phosphorylation and roles in wound healing response.
Citations are noted in brackets.
Phosphoprotein (site)
p-CREB (Ser133)
p-HSP27 (Ser78)
p-IκBα (Ser32/Ser36)
p-MEK1
(Ser217/Ser221)
p-S6RP
(Ser235/Ser236)
p-Smad2
(Ser465/Ser467)
p-Src (Tyr416)
p-Syk (Tyr352)
p-c-Jun (Ser63)
p-AKT (Ser473)
p-p53 (Ser15)
p-p38 (Thr180/Tyr182)
p-p70S6K (Ser380)
p-PTEN (Ser380)
p-ZAP-70 (Tyr319)
p-BAD (Ser136)
p-ERK1/2
(Thr202/Tyr204)
p-GSK-3α/β
(Ser21/Ser9)
p-p90RSK (Ser380)
p-VEGFR2 (Tyr1175)
p-NF-κB p65 (Ser536)

Relevant Functions in Acute Wound Healing Response
Inhibition of CREB via phosphorylation promotes wound closure
[30]
Activation of HSP27 may inhibit stress-induced apoptosis [31]
Pro-wound healing, inhibits actions of NF-κB [32]
Essential for migration of epithelial layers [33]
Activated during proliferative growth phase [30]
Regulates keratinocyte migration during proliferation [34]
Promotes keratinocyte migration in wound healing [32]
Important for cellular migration in wound healing [35]
Induces apoptosis of immune cells in skin wound healing [33]
Phosphorylation of AKT promotes wound closure [30]
Activated p53 accelerates cutaneous wound healing by increasing
cell proliferation [36]
Activated p38 involved in muscle catabolism [32]
Growth factor associated with cell proliferation [37]
Pro-apoptotic, inhibits acute wound healing [38]
Stimulates cell migration during wound healing [35]
Phosphorylation of BAD activates pro-apoptotic functions [39]
Important for early proliferative response in wound healing [37]
Controls wound healing and fibrosis progression [30]
Downstream effector of MEK/ERK pathway in wound healing,
regulator of cell migration [40]
Stimulates angiogenic cascade during re-epithelialization [41]
Linked to muscle atrophy and catabolism [32]
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4.2.5 Data processing and statistical analysis
Data were analyzed using Prism 5 (GraphPad, San Diego, CA) and SAS JMP (Cary, NC).
Cytokine standard curves were generated using either a four- (4PL) or five-parameter logistic (5PL)
regression model, depending on the individual protein. Cytokine concentrations are expressed as
picograms of cytokine per milliliter of tissue homogenate (pg/mL). For purposes of network
analyses, these values were normalized to the highest value for each cytokine. For phosphoproteins,
relative phosphoprotein levels were measured via multiplex enzyme-linked immunosorbent assay
(ELISA), and compared to negative control. These values were normalized to the highest value for
each phosphoprotein. Contributions of cytokines and phosphoproteins were analyzed for the ATL
and RTL layers. All four tissues from the ATL layer were averaged together to represent ATL
depth. The three tissues from the RTL layer were averaged together to represent RTL depth.
Samples with fluorescence intensity values below the lower limit of quantitation (LLOQ) or above
the upper limit of quantitation (ULOQ) were omitted from statistical comparisons of cytokines and
phosphoproteins. Outliers were identified using the 1.5 X interquartile range (IQR) rule and
omitted from analysis [45]; these were removed on a case-by-case basis to exclude errant values
that may have resulted due to assay variability. Two-way analysis of variance (ANOVA) with
Bonferroni’s post-test was used to determine significant differences between primary TKA, aseptic
TKR, and septic TKR tissue samples at each tissue depth, ATL and RTL. Data are expressed as
the mean ± standard error of the mean (SEM). To examine any potential confounding factors in
this cohort, Pearson correlations were analyzed between age, sex, and BMI and all 30 measured
targets. A Bonferroni’s correction was applied, as described in [46], and the correlations were
analyzed for statistical significance at p < 0.05. Although there are established correlations in
literature between inflammatory mediators and age, sex, and BMI, there were no statistically
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significant correlations observed for this study, which indicates that these parameters were not
confounding factors (data not shown).

4.2.6 Network evaluation with Ingenuity Pathway Analysis (IPA)
The normalized responses of each target were investigated with QIAGEN’s Ingenuity®
Pathway Analysis (IPA®, QIAGEN, Redwood City). Proposed signaling networks of cytokines
and phosphoproteins were created for all groups (primary TKA, aseptic TKR, septic TKR) at the
ATL depth. All networks consist of nodes from the experimental dataset and literature-derived
projected nodes likely to be involved, identified by Ingenuity Knowledge Base. Up- and downregulated responses are color coded using red and green, respectively. Briefly, IPA constructs
networks building on “Focus Genes” or nodes that are highly interconnected [47]. Values from the
experimental dataset influence which nodes are designated as “Focus Genes” and may alter the
structure of the networks. IPA also reported top molecular and cellular functions related to the
network, with corresponding scores (negative log10 [p-value of Fisher’s exact test]). The Fisher’s
exact test (p-value) gives the likelihood of finding the identified Focus Genes by random chance
in the Global Molecular Network used by IPA.

4.2.7 Network centrality parameter analysis
Euclidean distances between pairs of normalized observations (cytokines and
phosphoproteins) were determined for each group (primary, aseptic, septic) and depth (ATL and
RTL). The definition of Euclidean distance is given in Equation 4.1:
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𝑛

2

𝐸(𝜐, 𝜔) = √∑ ((𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑟𝑒𝑠𝑝𝑜𝑛𝑠𝑒𝜐𝑖 ) − (𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑟𝑒𝑠𝑝𝑜𝑛𝑠𝑒𝜔𝑖 ))

(4.1)

𝑖=1

where υ and ω represent the 2 responses for which the distance between is being calculated, and n
signifies the replicate number. To construct networks of the relative responses of each group,
Euclidean distances for each pair of nodes were used to calculate the node centrality parameter,
radiality. Radiality is defined as:

𝐶𝑟𝑎𝑑(𝜐) =

∑𝜔𝜖𝑁(𝐺 + 1 − 𝑑𝑖𝑠𝑡(𝜐, 𝜔))
𝑛−1

(4.2)

where G represents the network (N) diameter (maximal path length of the network), dist(υ,ω) is
the shortest path between a pair of nodes υ and ω, and n is the number of nodes in the network
(Equation 4.2). To allow for comparisons between networks, radiality values were normalized to
the average radiality for all nodes in the network. Significant radiality values were identified using
a threshold value of the average radiality ± the standard deviation.

Results
4.3.1 Relative spatial cytokine responses
Nine cytokines were measured in this study: IL-1α, IL-1β, IL-4, IL-6, IL-10, IL-12p70, IL13, IFN-γ, and TNF-α. The responses of these cytokines are shown in Figure 4.2. Cytokine levels
were normalized across groups (primary TKA, aseptic TKR, septic TKR) and debridement depths
(ATL, RTL) to the highest value for each cytokine. Normalizing by this method is important to
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appropriately weight cytokines equally for network analysis rather than relying on raw
concentrations. This weighting is performed to understand the contributions of each node to the
network, relative to other nodes. Group-dependent differences were observed, as were spatial
differences between debridement depths. Briefly, the aseptic TKR and septic TKR groups had
higher cytokine responses than the primary TKA group for all cytokines. IL-1α, IL-1β, IL-4, and
IL-6 had higher levels in septic TKR than aseptic TKR at a statistically significant level (p < 0.05).
IL-10 was the only cytokine with a lower relative response in the septic TKR when compared to
aseptic TKR at a statistically significant level (p < 0.05). IL-12p70 seemed to show the same trend,
but was not significant at p < 0.05. There were also differences between ATL and RTL in septic
TKR tissues. For IL-1α, IL-1β, and IL-4, there were statistically significant differences between
ATL and RTL depths for the septic group (p < 0.05).
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Figure 4. 2. Relative cytokine levels measured in tissues from primary TKA, aseptic TKR, and
septic TKR at adjacent tissue layer (ATL) and radial tissue layer (RTL) debridement depths.
Relative cytokine responses (normalized to highest cytokine signal) were observed for all three
patient groups: primary, aseptic, and septic at two debridement depths: ATL is closer to the knee
joint, and RTL is approximately 1 cm removed from the knee joint. Statistically significant
differences (p < 0.05) were determined by two-way ANOVA with Bonferroni’s post-test to
examine group-dependent and spatially-dependent differences in cytokine relative response.
Differences for the same group (i.e., septic) between ATL and RTL are marked with an asterisk
(*). Differences between groups within a tissue layer are denoted with bars. Responses are shown
as the mean ± SEM.
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4.3.2 Relative spatial phosphoprotein responses
To further investigate the impact of the observed cytokines on tissue response, twenty-one
phosphoproteins were measured: p-CREB, p-HSP27, p-IκB-α, p-MEK1, p-S6RP, p-Smad2, p-Src,
p-Syk, p-c-Jun, p-AKT, p-p53, p-p38, p-p70S6K, p-PTEN, p-ZAP-70, p-BAD, p-ERK1/2, pGSK-3α/β, p-p90RSK, pVEGFR2, and p-NF-κB (more information can be found in Table 4.3).
The data are spread over Figures 4.3, 4.4 and 4.5. Figure 4.3 includes phosphoproteins most
associated with proliferative wound healing processes [30,36,37,39]. Phosphoproteins in Figure
4.4 have roles in cell migration and fibrotic processes [2,30,32,34,35,40,41]. Finally, Figure 4.5
includes the phosphoproteins that have pro-apoptotic roles and have been associated with delayed
wound healing through their involvement in muscle catabolism [33,38–40]. Most phosphoproteins
exhibited higher responses in the primary TKA tissues than in aseptic TKR and septic TKR tissues,
for both ATL and RTL depths, and many exhibited group-dependent differences, especially in
ATL depth. Some exceptions to this trend were p-c-Jun and p-BAD, which had the highest
responses in aseptic TKR, then septic TKR, followed by primary TKA; also, p-PTEN showed the
highest response in septic tissues (Figure 4.5). Specific group-dependent comparisons are shown
in Figures 4.3–4.5.

Tissue depths were also compared for phosphoproteins. Responses in the ATL were higher
than responses in the RTL for most phosphoproteins. However, several proteins showed notably
higher levels in RTL than ATL for at least one of the three tissue groups: p-BAD, p-Src, p-IκB-α,
p-HSP27, p-ERK1/2, and p-VEGFR2 (Figures 4.3–4.5). Comparisons of ATL vs. RTL for each
group are shown in Figures 4.3–4.5.
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Figure 4. 3. Relative levels of phosphoproteins associated with the proliferative processes in acute
wound healing. Relative phosphoprotein responses (normalized to highest signal) were observed
for all three patient groups: primary, aseptic, and septic at two debridement depths: ATL is closer
to the knee joint, and RTL is approximately 1 cm removed from the knee joint. Statistically
significant differences (p < 0.05) were determined by two-way ANOVA with Bonferroni’s posttest to examine group-dependent and spatially-dependent differences in protein phosphorylation.
Differences for the same group (i.e., septic) between ATL and RTL are marked with an asterisk
(*). Differences between groups within a tissue layer are denoted with bars. Responses are shown
as the mean ± SEM.
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Figure 4. 4. Relative phosphoprotein levels associated with cell migration processes in acute
wound healing. Relative phosphoprotein responses (normalized to highest signal) were observed
for all three patient groups: primary, aseptic, and septic at two debridement depths: ATL is closer
to the knee joint, and RTL is approximately 1 cm removed from the knee joint. Statistically
significant differences (p < 0.05) were determined by two-way ANOVA with Bonferroni’s posttest to examine group-dependent and spatially-dependent differences in protein phosphorylation.
Differences for the same group (i.e., septic) between ATL and RTL are marked with an asterisk
(*). Differences between groups within a tissue layer are denoted with bars. Responses are shown
as the mean ± SEM.
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Figure 4. 5. Relative levels of pro-apoptotic and inhibitory wound healing phosphoproteins in
acute wound healing. Relative phosphoprotein responses (normalized to highest signal) were
observed for all three patient groups: primary, aseptic, and septic at two debridement depths: ATL
is closer to the knee joint, and RTL is approximately 1 cm removed from the knee joint.
Statistically significant differences (p < 0.05) were determined by two-way ANOVA with
Bonferroni’s post-test to examine group-dependent and spatially-dependent differences in protein
phosphorylation. Differences for the same group (i.e., septic) between ATL and RTL are marked
with an asterisk (*). Differences between groups within a tissue layer are denoted with bars.
Responses are shown as the mean ± SEM.
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4.3.3 IPA-generated networks
Networks for the three groups (primary TKA, aseptic TKR, and septic TKR) were
constructed from the same set of cytokines and phosphoproteins for the ATL layer. The network
connectivity varied greatly between the three groups (Figure 4.6). Qualitatively, the primary TKA
network showed higher connectivity and more experimentally validated up- and down-regulation
of targets, as shown by the red and green coloring, respectively. Further, the connections between
targets, also known as “edges,” varied between the three groups. Edges denote connections
between nodes; in IPA, direct relationships are shown by solid lines, and indirect relationships are
shown by dotted lines. The primary TKA network showed 139 edges; 23 of these edges were direct,
and 116 were indirect. For aseptic TKR, 65 total edges were identified: 4 direct, 61 indirect. For
septic TKR, 61 total edges are shown: 4 direct and 57 indirect. IPA uses the experimental dataset
to identify related IPA networks, shown in Table 4.4. A p-score is shown for each IPA network
match, and the p-score is calculated based on the -log10(p-value) for the Fisher’s exact test. A
higher IPA p-score indicates a stronger match; p scores above 21 are generally considered good
matches [48].
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Figure 4. 6. Ingenuity Pathway Analysis (IPA)-generated networks for primary TKA, aseptic TKR,
and septic TKR groups based on cytokine and phosphoprotein datasets. Proposed networks used
relative cytokine and phosphoprotein responses in the ATL depth, illustrating the differences in
tissue responses for the three groups. The nodes are illustrated in a “heat map” coloring scheme,
with red denoting up-regulation, green denoting down-regulation, and the intensity of color
correlates to the intensity of relative response. The networks are supplemented with other nodes
likely to be involved, as identified in the Ingenuity Knowledge Base. A solid line represents a
direct interaction between two nodes, while a dotted line denotes an indirect relationship.

Table 4. 4. Top 2 IPA Networks for Primary TKA, Aseptic TKR, and Septic TKR Groups. Network
p-scores are calculated by IPA using the negative log10 (p-value) of Fisher’s exact test. The p-value
describes the probability of finding the cytokines/phosphoproteins randomly in the databases
utilized by IPA to construct the network. Networks with p-scores above the threshold of 21 are
bolded.
Primary TKA
IPA Network
Cell-mediated immune
response, cellular
development, cellular
function and
maintenance
Cancer, organismal injury
and abnormalities, cell
cycle

Aseptic TKR
pscore

IPA Network

72

Inflammatory response,
cellular movement, cell
death and survival

2

Cell-mediated immune
response, cellular
development, cellular
function and
maintenance
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Septic TKR
pscore

IPA Network

pscore

16

Cellular movement,
inflammatory response,
hematological
development and
function

16

9

Cell death and survival,
organismal injury and
abnormalities, cellular
development

9

4.3.4 Normalized radiality of all 30 nodes

Based on the ANOVA data and IPA-generated networks, all of these cytokine and
phosphoprotein targets have roles to play in both infection response and wound healing. To further
understand the most important targets, network centrality parameter analysis was performed by
analyzing a network centrality parameter, radiality. Radiality values were determined for each
cytokine and phosphoprotein node and normalized to the average radiality for the network (e.g.,
primary TKA, ATL layer). These values are presented in Tables 4.5 and 4.6. Changes in significant
radiality outcomes can allow for a better understanding of the “drivers” of each network and
deviations from normal response (Figure 4.7). Nodes with significant radiality values are bolded;
the significance threshold used was the average radiality ± standard deviation. Based on previous
work [49], we expect significant radiality outcomes with low radiality values to be the most likely
drivers of the dysregulation for persistent inflammation and infection of aseptic and septic TKR,
respectively.
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Table 4. 5. Normalized Radiality of Nodes in the ATL Layer. Significant target values for each
individual network are bolded (significance threshold: the average radiality ± standard deviation).
Node

ATL Primary TKA

ATL Aseptic TKR

ATL Septic TKR

p-CREB

0.96

0.77

1.15

p-HSP27

1.13

1.14

1.15

p-IκBα

1.13

1.16

1.10

p-MEK1

1.13

1.08

1.10

p-S6RP

1.13

0.98

1.13

p-Smad2

1.13

1.15

1.14

p-Src

1.13

1.15

1.15

p-Syk

1.13

1.11

0.95

p-c-Jun

1.04

0.77

1.03

p-AKT

1.10

0.99

1.08

p-p53

1.13

1.00

1.06

p-p38

1.13

1.05

1.06

p-p70SK6

1.13

1.15

1.07

p-PTEN

1.09

1.02

0.76

p-ZAP-70

1.13

1.16

1.07

p-BAD

0.96

0.77

1.15

p-ERK1/2

1.13

1.15

1.13

p-GSK-3a/b

1.13

1.16

1.12

p-p90RSK

1.13

0.99

1.04

p-VEGFR2

1.13

0.99

1.11

p-NF-kB

1.13

1.16

1.09

IL-1b

0.62

0.91

0.76

IL-4

0.90

1.01

0.76

IL-6

0.60

0.82

0.76

IL-1a

0.63

1.15

0.76

IL-10

0.73

0.79

1.02

IL-12p70

0.84

0.77

1.06

IL-13

0.84

0.77

0.76

IFN-y

0.85

0.96

0.76

TNF-a

0.85

0.93

0.76
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Table 4. 6. Normalized Radiality of Nodes in the RTL Layer. Significant target values for each
individual network are bolded (significance threshold: the average radiality ± standard deviation).
Node

RTL Primary TKA

RTL Aseptic TKR

RTL Septic TKR

p-CREB

1.12

0.79

1.06

p-HSP27

0.87

1.12

1.03

p-IκBα

1.07

1.13

1.01

p-MEK1

0.99

1.05

1.08

p-S6RP

1.06

0.98

1.02

p-Smad2

1.12

1.11

1.10

p-Src

0.97

1.08

1.04

p-Syk

1.01

0.96

0.94

p-c-Jun

1.11

0.97

0.99

p-AKT

0.80

1.12

1.09

p-p53

0.97

1.07

1.00

p-p38

1.11

1.08

1.06

p-p70SK6

0.80

1.13

1.00

p-PTEN

1.12

1.12

1.05

p-ZAP-70

1.11

0.96

1.07

p-BAD

1.12

0.79

1.06

p-ERK1/2

0.83

1.09

1.11

p-GSK-3a/b

1.12

1.12

1.02

p-p90RSK

1.10

1.00

0.95

p-VEGFR2

1.09

1.13

1.10

p-NF-kB

1.04

1.12

1.04

IL-1b

0.85

0.99

1.08

IL-4

1.04

1.03

1.00

IL-6

0.82

0.89

1.11

IL-1a

0.84

1.09

1.11

IL-10

0.95

0.64

0.70

IL-12p70

0.96

0.92

1.07

IL-13

1.01

0.74

0.59

IFN-y

1.01

0.75

0.73

TNF-a

1.00

1.00

0.80
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While several nodes were significant within each of the six networks, respectively, some
nodes showed a group-dependent trend in significance (Tables 4.5 and 4.6). There were changes
in significance between the native primary TKA response and aseptic or septic TKR responses. In
the primary TKA networks, IL-1α, IL-1β, IL-6, and IL-10 gave significant low radiality outcomes
for the ATL; p-HSP27, p-AKT, p-ERK1/2, IL-1α, IL-1β, and IL-6 were significant in the RTL.
Differences for the aseptic TKR group include p-CREB, p-c-Jun, p-BAD, IL12p70, and IL-13 in
the ATL; p-CREB, p-BAD, IL-10, IL-13, and IFN-γ for the RTL. Deviations in the septic TKR
group include p-PTEN, IL-4, IL-13, IFN-γ, and TNF-α in the ATL layer and IL-10, IL-13, IFN-γ,
and TNF-α in the RTL layer.
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Figure 4. 7. Changes in significant nodes between groups for low radiality outcomes. Nodes with
low radiality outcomes that differed between primary TKA response and aseptic/septic TKR
responses are shown (significance threshold: the average radiality ± standard deviation). Boxes
indicate significance at varying depths. IL-10 is shown in red to highlight its presence in all three
groups: primary TKA, aseptic TKR, and septic TKR. IL-13 (green) and IFN-γ (blue) are also
colored to highlight overlap in both aseptic TKR and septic TKR groups.
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Discussion
The cytokine and phosphoprotein targets measured in this study are known to be significant
contributors to inflammatory responses in general [2], but the interconnected relationships of these
targets remain to be elucidated for PJI. Further, many of these targets have not been studied on a
tissue level for chronic inflammation and infection, so much of the dysregulation that occurs in
immune response and wound healing processes remains unknown [12]. Relative cytokine and
phosphoprotein responses were measured to understand the trends in response across three groups
of patients: primary TKA, aseptic TKR, and septic TKR at two tissue depths: ATL and RTL.
Higher relative cytokine levels were observed in either aseptic or septic TKR samples compared
to primary TKA tissues. IL-1α, IL-1β, IL-4, and IL-6 showed infection-specific relative responses,
with higher levels in septic TKR than both aseptic TKR and primary TKA (p < 0.05, Figure 4.2).
These cytokines have been identified in literature as important early immune response mediators
in PJI [50]. Additionally, there were spatial differences between ATL and RTL layers for IL-1α,
IL-1β, IL-4, and IL-10 (Figure 4.2). The spatial discrepancies observed in this study suggested that
the cytokine response is more robust in the ATL layer of septic tissues compared to the RTL. The
spatial relationships were unclear for primary TKA and aseptic TKR using ANOVA comparisons
(Figure 4.2).

Phosphoproteins were also included in this analysis as many hold central roles in early
infection response [4]. The phosphoproteome has not been thoroughly investigated for chronic
joint inflammation and infection in PJI, but the relationships between cytokines and
phosphoproteins may reveal important information considering the central role of these signaling
proteins in cell cycle regulation [9], cell proliferation [36], inflammatory processes [49], and
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wound healing [30]. Most phosphoproteins were found in higher levels in primary TKA tissues
(Figures 4.3–4.5). While the septic TKR gave the highest response of most cytokines, it often
showed the lowest levels of phosphoproteins (Figures 4.3–4.5). While many of the
phosphoproteins tested are downstream targets of cytokines [2,32,33,38,40–43], decreased levels
of wound healing-associated phosphoproteins have previously been observed in other studies
[14,15]. Notable exceptions were p-c-Jun and p-BAD, which were highest in aseptic TKR, and pPTEN, which was highest in septic TKR (Figure 4.5). All three of these phosphoproteins have
associated pro-apoptotic functions in acute wound healing [33,38,39], which may be related to
their increased phosphorylation in aseptic and septic TKR tissues, respectively. Phosphoprotein
levels also showed spatial trends between ATL and RTL at a statistically significant level (p <
0.05) for p-IκB-α, p-GSK-3α/β, p-Smad2, and p-CREB (Figures 4.3,4.4). All four of these
phosphoproteins are related to cell migration and proliferation, and have important roles for wound
healing [30,32,34]. The results of this study showed higher levels for these phosphoproteins in the
ATL of primary TKA, compared to RTL of primary TKA, which suggests tissues closer to the
joint have increased wound healing activity (Figures 4.3,4.4).

While traditional ANOVA comparisons gave information about the relative responses of
cytokines and phosphoproteins, chronic inflammation and infection involve a series of deeply
interconnected targets [3,12], which makes it difficult to fully understand the tissue responses
when only considering each target in isolation. The ANOVA data alone do not fully explain which
targets may be contributing most to the disruptions in responses observed in aseptic and septic
TKR. IPA analysis was used to comparatively assess the connectivity between the three groups.
IPA has proven to be a useful tool for visualizing the connectivity of different nodes (i.e., genes,
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proteins, etc.) involved in networks [53]. Figure 4.6 illustrates the utility of IPA for comparing
different networks qualitatively and depicts the differences between primary TKA, aseptic TKR,
and septic TKR networks for each of the ATL layers. The primary TKA shows better connectivity
between targets than aseptic TKR and septic TKR, suggesting there may be dysregulation
occurring in both aseptic and septic TKR tissues (Figure 4.6). Additionally, Table 4.4 lists the top
IPA network hits for each of the three networks. For proteomic analysis, a p-score above 21 is
considered a good match [48]. Only the primary TKA network was able to make a match above
this threshold. Based on the IPA analysis, both aseptic TKR and septic TKR networks show a lack
of connectivity compared to primary TKA, which may prevent a reliable IPA network match
(Table 4.4).

A network centrality approach was also utilized to quantitatively assess which targets were
close to (high radiality) or distant from (low radiality) the center of each of the networks. Radiality
comparisons may reveal the most likely nodes contributing to the dysregulation observed in the
IPA networks. Based on previous work in a rodent model of trauma [49], we expect that differences
in nodes with low radiality between primary TKA response and aseptic or septic TKR responses
may indicate the most likely causes of disruptions to normal signaling. In this study, low radiality
outcomes were the most likely contributors to cell signaling dysregulation leading to chronic
inflammation and infection. A significance threshold of the average radiality ± standard deviation
was used to denote significant cytokine and phosphoprotein nodes (Tables 4.5 and 4.6).
Differences existed in significant nodes across groups and between depths.

147

The primary TKA group represents the native response, as these tissues are not in contact
with implants or infection that cause persistent inflammation [51,52]. In primary TKA, all
significant nodes in the ATL had low radiality values, and all four were cytokines: IL-1α, IL-1β,
IL-6, and IL-10. Within this network, these cytokines appear to be acting as regulatory molecules.
IL-1α, IL-1β, and IL-6 are all pro-inflammatory cytokines vital for early inflammatory immune
response [6,8]. The anti-inflammatory IL-10 is central for wound resolution [54]. In the RTL of
primary TKA, nodes with significant low radiality values were p-HSP27, p-AKT, p-ERK1/2, IL1α, IL-1β, and IL-6 (Tables 4.5 and 4.6). This suggests that there is still a significant contribution
of pro-inflammatory cytokines in healthy tissues spatially removed from the joint. p-HSP27, pAKT, and p-ERK1/2 have all been linked to early proliferative wound healing responses in trauma
[55] and skin wounds [56]. Their low radiality outcomes suggested that these three
phosphoproteins may be driving the tissue healing response. Additionally, in the RTL of primary
TKA, seven phosphoproteins had significantly high radiality values (Table 4.6), suggesting that
there is an organized wound healing response in tissues further away from the joint.

The aseptic and septic TKR groups were compared to the primary TKA group to
understand differences in radiality outcomes. In the aseptic ATL, nodes with significant low
radiality outcomes were p-CREB, p-c-Jun, p-BAD, IL-6, IL-10, IL-12p70, and IL-13. Additionally,
eight phosphoproteins and one cytokine had significant high radiality outcomes (Table 4.5).
Overall, in the ATL of aseptic TKR, there appears to be a balance of regulated and dysregulated
healing processes. In combination with the IPA network results, this suggested that dysregulation
may be caused by reduced contributions for pro-inflammatory IL-1α and IL-1β and an increased
role for anti-inflammatory IL-13 between primary TKA response and aseptic TKR response at the
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joint (Figure 4.6). The pro-apoptotic actions of peripheral p-c-Jun and p-BAD [33,39], and
inactivation of CREB [57] in aseptic TKR could also be driving these disruptions (Figures 4.64.7). In the RTL of aseptic TKR, p-CREB, p-BAD, IL-10, IL-13, and IFN-γ gave significant low
radiality outcomes (Table 4.6). The aseptic RTL tissues showed a shift to all significant nodes
showing low radiality outcomes (Table 4.6). Compared to the primary RTL, there is a notable
induction of anti-inflammatory cytokines IL-10, IL-13, and IFN-γ. Significance of p-CREB and
p-BAD suggested these activated proteins may be promoting apoptosis [30,39] in presumably
healthy aseptic tissues. Further, the coordinated healing response observed in primary RTL tissues
is no longer present, as there were no significant high radiality outcomes in aseptic RTL (Table
4.6). Even in the clinically “healthy” tissues for the aseptic group, there is a large amount of
dysregulation present, and it appears to be primarily driven by these seven targets: p-c-Jun, pCREB, p-BAD, IL-10, IL-12p70, IL-13, and IFN-γ.

In septic TKR, nodes with significant low radiality outcomes in the ATL were p-PTEN,
IL-1α, IL-1β, IL-4, IL-6, IL-13, IFN-γ, and TNF-α. Notably, there were no significant high
radiality outcomes (Table 4.5). While this may somewhat reflect the strong cytokine-dependent
response observed in primary TKA, differences include increased contributions of antiinflammatory IL-4, IL-13, and IFN-γ, pro-inflammatory TNF-α, and pro-apoptotic p-PTEN in the
septic TKR group. The ATL of septic TKR showed a notable induction of anti-inflammatory
cytokines not observed in the primary TKA. In the septic RTL layer, IL-10, IL-13, IFN-γ, and
TNF-α gave significant low radiality values. There were no significant outcomes with high
radiality values in this network (Table 4.6). Additionally, there was no overlap in significant low
radiality targets between primary TKA and septic TKR tissues at the RTL depth. This loss of
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centrality for wound healing targets in the “healthy” septic TKR tissues reflects a disruption in
normal response.

There were some limitations to the study. A single surgeon collected all tissue samples for
the cohort of patients involved. Treatment of PJI via debridement is a subjective assessment of
tissue viability [28], so the delineation between “healthy” and “unhealthy” tissues may vary
between surgeons. The results for the RTL depths of aseptic and septic TKR highlighted the
disruptions still present in presumably healthy tissues removed from the joint, so a larger cohort
of patients from different surgeons may aid future studies in analyzing these targets. Further, it is
difficult to fully disentangle the inflammation present in native response from chronic
inflammation and infection. The primary TKA group is expected to experience inflammation as a
result of the surgery [58], which is why this study focused on outlining the differences between
groups. These differences may not account for all inflammation occurring in the tissues, but the
discrepancies between targets may help identify the dysregulation observed in aseptic and septic
TKR. Differences in tissue composition (including bone, cartilage, and synovium) may also have
played a role in introducing variability between cytokine and phosphoprotein levels; this study
focused on including the most likely tissues taken from debridement, regardless of composition.
Finally, the IPA analysis was only qualitatively useful in this case due to experimental constraints.
While IPA can be used quantitatively for proteomics [59], the samples must be normalized to a
control group. The primary TKA is not a true control, only a comparative group. In human subjects,
we cannot ethically collect a true tissue control (i.e., healthy individuals with no inflammation
present), which limited our ability to analyze via IPA. However, the qualitative comparison at the
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joint still supported the network centrality analysis, and the IPA provided some confirmation of
the roles of the targets involved.

Conclusion
The acute intra- and extracellular responses to infection have been studied extensively, and
these studies have provided valuable information for clinicians to develop diagnostics and
therapeutics to combat these infections [50]. However, less is known about the dysregulation that
occurs when inflammation and infections become chronic, which is the case in localized infections
like PJI [12]. In this study, we aimed to define the impact of individual cytokines and
phosphoproteins on chronic inflammation and infection in PJI using a network centrality parameter
approach. Overall, network centrality analysis showed the native response in primary TKA tissues
was dictated by a balance of pro- and anti-inflammatory cytokines. Tissues in the ATL were highly
influenced by pro-inflammatory cytokines IL-1α, IL-1β, and IL-6 and anti-inflammatory IL-10. A
variety of pro-inflammatory cytokines and wound healing phosphoproteins were central to the
network in the RTL, and this response was reflective of normal tissue healing processes [8,30,43].
Deviations from this response were observed in both aseptic and septic TKR groups. In aseptic
TKR tissues, a shift to increased peripheral roles for pro-apoptotic and anti-inflammatory targets
was prevalent at both ATL and RTL tissue depths. In the septic ATL layer, pro-apoptotic p-PTEN
and anti-inflammatory cytokines IL-4, IL-13, and IFN-γ showed significant losses of centrality
compared to primary TKA. The high contributions of nodes with seemingly contradictory roles,
combined with the loss of overall IPA network connectivity, highlights the dysregulation near the
joint in septic TKR tissues. At the septic RTL depth, anti-inflammatory cytokines dominated the
response, showing a hallmark absence of coordinated phosphoproteins linked to wound healing.
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The radiality data as a whole suggested that disrupted signaling pathways are present for both
aseptic and septic TKR, even in presumably “healthy” tissues. Targeting the proteins with
significant radiality outcomes in chronic inflammation and infection may prove useful for
developing more effective therapeutics, and future studies should focus on these proteins to
promote tissue healing and infection resolution in PJI.
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Chapter 5
Conclusions and Future Directions: Translating Signal Transduction
Research into Clinically-Relevant Tools
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The work presented in this dissertation was aimed towards improving the understanding of
chronic, localized infections through analysis of signal transduction pathways and represents one
example of a basic research approach to a clinical problem, chronic infection. It began with an
investigation of a clinical cohort to identify biomarkers of chronic PJI at two spatial gradients, then
moved onto further probing of upstream and downstream effects of infection using an in vivo
model. Finally, it culminated with validation of network centrality radiality analysis of signal
mediators to understand drivers of disrupted responses observed in the clinical and in vivo studies.
It represented a novel approach to prospective, tissue-level investigations of cell signaling changes
in response to inflammatory stimuli, and the analyses demonstrated that distinct inflammatory
immune and wound healing profiles exist in response to implants and chronic implant infections
compared to native tissues. Based on this work, it was clear that both implants and chronic joint
infections provoke cell signaling changes that negatively impact immune and wound healing
responses on a tissue level.

This research laid a foundation to better understand the tissue-level response to chronic
infection, but there is more work to be done before it can be translated into the clinic. The final
chapter of this dissertation will discuss important next steps for this work and implications for
similar investigations. This work was the initial attempt to investigate the implications of tissuelevel disruptions caused by chronic infection (e.g., tissue viability), and the use of ‘omics
technologies and newly emerging analytical techniques promise exciting progress in follow-up
investigations of these signal transduction networks. The success in translation of this signal
transduction work into the clinic will rely on comprehensive analyses of mediators involved, use
of data integration techniques, and compatibility with expeditious results and interpretation.
161

Localized vs. Systemic Investigations of Clinical Pathologies
An important consideration for signal transduction studies is whether to focus efforts on the
localized response in individual organs or tissues or the systemic response in blood and other
biological samples. The research goals of the study dictate the correct choice, and a variety of
studies have investigated relationships between localized and systemic responses in disease states.
Systemic measurements can prove beneficial for a variety of non-invasive applications, such as
point-of-care diagnostics, in which samples can easily be acquired from blood or other fluids with
minimal processing, providing a rapid means of obtaining clinical information. Studies concerned
with infection or sepsis have concluded that both local and systemic information can be useful,
and immune-related factors- such as cytokines- have been utilized as biomarkers on either level.
Monitoring circulating levels of immune-related cytokines has proven useful for a range of
clinically-relevant applications, including determining the presence of infection [1, 2], monitoring
risk and severity of sepsis [3], and differentiating between types of infections [4, 5]. Systemic
levels of immune mediators have also been pursued for other pathological conditions. Serum
biomarkers have been identified in cancers to monitor drug efficacy [6] or predict adverse
outcomes [7]. Concentrations of extracellular matrix proteins in serum have shown utility for
monitoring tissue healing in chronic obstructive pulmonary disorder (COPD) [8]. Even tears [9]
and saliva [10] have been used as mediums to better understand the immune response to stress and
disease. Most of these systemic measurements are best suited for monitoring immune response
over time or predicting adverse outcomes.

Localized investigations can highlight the ability of specific organs or tissue types to counter
immune-related insults like infection, and these responses may differ with proximity, as
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demonstrated in Chapters 2 and 3. Different tissues are composed of different cell types, and
variability of responses may arise due to tissue composition, further highlighting the importance
of considering a localized perspective for signal transduction research. Several studies have
demonstrated differences between local and systemic immune environments [11], and localized
profiles of immune mediators have been investigated in models of infection to understand the
tissue-specific response [12, 13], including the work presented in this dissertation. Localized
investigations have also been pursued for other conditions, and Hauser et al. demonstrated that the
immune microenvironment differs between localized and circulating levels in response to human
fracture and soft-tissue trauma [14]. Similarly, Currie et al. characterized the spatial gradients of
immune and wound healing factors in a traumatic injury model in rodents to show that proximity
dictates the response [15, 16]. Differences in localized and systemic profiles were investigated in
organ failure with similar conclusions, that these localized perspectives offered tissue-specific
insights relevant to disease management [17]. These studies illustrated that these responses might
vary considerably depending on tissue type, and a localized approach is necessary to understand
the specific responses of tissues and the effects on signal transduction cascades that arise following
these insults. The spatial investigation conducted in this work demonstrated that spatial gradients
exist in the tissue-level response to implants and infection, and tissues closer to the joint showed
higher concentrations of cytokines and higher degrees of protein phosphorylation, so proximity is
an important factor in the immune and wound healing responses. In the future, a comparison of
serum would inform clinicians of systemic-level inflammation, which is likely higher in patients
with aseptic and septic joints and could have negative implications for overall health.
Understanding the systemic effects of joint implants and joint infections is an important
consideration for Orthopaedists, but has not yet been addressed.
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Depending on an individual study’s intended outcomes, different spatial approaches may be
suitable. Systemic responses are beneficial for biomarker identification and non-invasive
monitoring of disease states, but studying localized responses in individual tissues or organs will
be critical to making clinical assessments of tissue health (e.g., debridement) more objective. A
localized approach was essential in this work to create a network of tissue-level responses to best
understand the response to infection, and similar studies may benefit when aiming to identify
healthy versus non-healthy tissues in response to stress, insults, and other diseases.

Integrating Multi-‘Omics Data to Approach Clinical Problems
Probing biological networks on a tissue level in response to infection elucidated the
interactions of highly interconnected targets, resulting in improved knowledge of the drivers of
signaling and the potential points of disruption. In Chapter 4, changes in networks resulting from
implant and infection were analyzed; Using network centrality radiality, it became possible to
identify which targets were likely driving the dysregulated response observed in these
inflammatory states. A thorough investigation of biological networks using mathematical
modeling is a relatively new analysis strategy in developing improved diagnostic and therapeutics
for many diseases [18, 19]. These network approaches often involve analyzing many targets
simultaneously, and these data can be acquired from multiple ‘omics platforms. This creates a
situation in which there are many more variables being tested than the number of replicates in the
study, which has introduced new challenges for interpretation.

Researchers must carefully consider what type of data to acquire and how best to integrate
different data sources to support their hypothesis. To fully understand a disease or insult, it may
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be necessary to investigate genetic factors, bioenergetics, immune response, or other elements.
While acquiring more data is often beneficial, it has become essential to develop new methods to
deal with these large data sets [20-22]. Translating multi-‘omics data into clinically-relevant
information is the next challenge in identifying markers of tissue health in chronic infection, and
these strategies could be applied to other investigations of cell signaling disruptions relevant to
disease. While the initial research into tissue health in chronic infection was pursued in Chapter 4
using network centrality, implementing other ‘omics techniques in the future- like metabolomics
and transcriptomics- could better inform the distinction between healthy and non-healthy tissue,
which is essential to develop useful clinical tools.

Investigating metabolomic profiles related to implants and chronic infection is the logical
next step towards improving tissue-level treatment. The cytokine and phosphoprotein data showed
shifts in tissue responses, but they did not fully explain the implications for tissue health. Cellular
metabolism changes are intimately linked to inflammatory response [30], and altered metabolite
profiles have been observed in response to inflammatory stimuli [31]. Studies of polar metabolites
have been used in literature to identify specific disruptions for a variety of pathological conditions
[32], as many polar metabolites play key roles in growth, development, and conversion of nutrients.
Targeting changes in these compounds could enlighten the distinct effects of chronic infection on
these wound healing-related processes. Metabolomic analysis coupled to previously collected
proteomic data on cytokines and phosphoproteins provides a means for pinpointing the specific
infection-related disruptions between aseptic and septic joints. Based on literature investigations
of skeletal muscle in other disease states, the prevailing hypothesis is that tissues responding to
implants and infection will show lower levels of important polar metabolites related to energy
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consumption (e.g., glucose, lactose). This shift will reflect the altered cellular states resulting from
chronic exposure to inflammatory stimuli. Long-term metabolic health of these tissues is of the
utmost importance to surgeons tasked with removing unhealthy and non-viable tissues.

New Technologies for Rapid Analysis
While many techniques are available to acquire data through multi-‘omics platforms,
clinical relevance is dependent on ease of acquisition and interpretation. Biological network
analysis of signal transduction networks is a complicated field, and researchers must keep this in
mind when seeking to translate their findings into clinically-relevant information. The work
presented in Chapters 2-4 heavily relied on multiplexed ELISA for data acquisition, but these
assays required 4-20 hours for data acquisition alone. While the specificity of ELISA techniques
was beneficial to lay the groundwork to understand targets of interest, this approach would not be
appropriate for intra-operative use to treat these chronic infections, so future research should
investigate the use of rapid analytical techniques to achieve this goal.

Advances in the field, such as rapid ELISA platforms [23, 24], miniature field-applicable
mass spectrometry [25], and other point-of-care testing have opened doors to advance the science
of biomarker detection [26, 27], and these platforms will prove essential to creating clinicallyrelevant means of analysis. While basic science investigations, like the work presented here, can
initially be used to identify markers of interest for disease, the ultimate goal is to provide a rapid,
sensitive platform for acquisition with results that can be easily interpreted in the clinic. Future
work to understand tissue viability in chronic infection or other disease states will benefit from
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utilizing these newly emerging analytical tools to provide this information quickly. Shotgun
metagenomic sequencing has been explored for fast identification of bacterial infection in synovial
fluids in infection and showed faster results than traditional ELISAs [28]. Ultrafast qRT-PCR gene
profiling coupled to machine learning algorithms has also demonstrated utility in establishing
biomarkers of tissue health, and a study by Fillerova et al. represents one of the few attempts to
characterize infection networks directly on a tissue level [29]. While this study included a smaller
cohort, researchers achieved 94.5% sensitivity and 95.7% specificity for infection diagnosis using
their algorithm and could provide diagnostic results within 45 minutes of sample collection.

The future of signal transduction-focused research to understand chronic inflammation and
infection will benefit from comparing local vs. systemic measurements and incorporating multi‘omics strategies to understand tissue health. Enrolling larger cohorts to include patients from
multiple surgeons is the next step to tackling these problems, allowing a broader spectrum of
expertise to delineate between healthy and unhealthy tissues and providing more tissue samples
dedicated to other ‘omics platforms. Additional animal studies should be performed to investigate
the temporal progression of immune and wound healing dysfunctions via transcriptomic and
metabolomic analyses, which could provide insight into the transition from acute to chronic
inflammatory states and enhance understanding of overall tissue viability relevant to surgical
debridement. Rapid analytical platforms will be critical in developing clinical tools from the
biomarkers identified in these studies to combat chronic inflammation and infection in the future.
Approaching these clinically-relevant problems through signal transduction network investigation
is key to improving current treatment methods, and the strategies utilized in these studies could be
applied to other disease states.
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APPENDIX A: CHAPTER 2 SUPPLEMENTARY FIGURES
Table A. 1. Average cytokine concentrations in the adjacent tissue layer (ATL). Concentrations in
the LG, F, T, and PC individual tissue locations were averaged to represent the response in the
ATL. Standard error of the mean (SEM) and number of patients in each of the primary TKA,
aseptic TKR, and septic TKR groups are also reported.

IL-1α
IL-1β
IL-6
IL-8
MIP-1α
MIP-1β
MCP-1
IL-4
IL-10
IL-12p70
IL-13
IL-17A
TNF-α

Primary TKA
ATL Avg
SEM
1.26
0.34
1.77
0.47
10.53
2.87
8.23
2.70
7.35
2.76
24.12
5.36
151.55
27.13
7.48
1.59
0.89
0.17
6.57
1.62
1.98
0.42
6.04
2.43
18.68
3.44

N
6
6
6
6
6
6
6
6
6
6
6
6
6

Aseptic TKR
ATL Avg
SEM
14.25
3.96
5.78
1.72
33.11
13.90
101.01
62.20
29.08
9.86
51.66
20.73
359.90
174.07
21.04
3.78
8.38
0.23
33.21
10.88
10.14
2.59
17.37
3.85
79.12
20.42

N
5
5
5
5
5
5
5
5
5
5
5
5
5

Septic TKR
ATL Avg
SEM
38.70
8.75
51.87
23.97
763.08
401.51
648.39
160.55
105.74
43.13
130.03
49.93
475.19
195.67
28.37
5.03
5.71
1.38
21.51
5.74
9.52
2.65
20.16
2.80
93.12
16.60

N
6
6
6
6
6
6
6
6
6
6
6
6
6

Table A. 2. Average cytokine concentrations in the radial tissue layer (RTL). Concentrations in
the LG, F, and T individual tissue locations were averaged to represent the response in the RTL.
Standard error of the mean (SEM) and number of patients in each of the primary TKA, aseptic
TKR, and septic TKR groups are also reported.
Primary TKA
RTL Avg
SEM
IL-1α
IL-1β
IL-6
IL-8
MIP-1α
MIP-1β
MCP-1
IL-4
IL-10
IL-12p70
IL-13
IL-17A
TNF-α

N

Aseptic TKR
RTL Avg
SEM

N

Septic TKR
RTL Avg
SEM

N

0.89
1.80
6.10
6.06
8.76
17.23
59.79
5.96
0.88
4.10
1.61
4.37

0.25
0.47
1.35
1.91
3.62
3.50
11.09
1.60
0.19
1.18
0.31
1.75

6
6
6
6
6
6
6
6
6
6
6
6

8.23
5.10
11.58
46.37
23.76
36.52
126.70
17.66
8.50
24.55
9.10
14.90

1.94
0.96
5.31
21.58
13.68
19.98
51.58
2.44
0.16
7.13
2.43
3.88

5
5
5
5
5
5
5
5
5
5
5
5

16.15
13.41
288.59
350.06
42.20
79.97
538.87
19.60
7.78
19.66
9.64
17.31

3.29
5.29
205.91
188.02
17.64
27.68
223.47
3.40
1.09
6.39
2.06
2.71

6
6
6
6
6
6
6
6
6
6
6
6

14.27

3.99

6

61.69

14.55

5

78.48

16.21

6
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CYTOKINE CONCENTRATIONS AT INDIVIDUAL LOCATION- INFECTIONSPECIFIC CYTOKINES
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Figure A. 1. Cytokine profiles in localized tissues in infection-specific inflammation. Average
cytokine concentration at individual tissue locations are shown for all groups. Two-way ANOVAs
with Bonferroni’s post-test were conducted to test for significant differences between groups at
each tissue depth (p<0.05). Significant differences between groups at a particular location are
marked as: P denotes significant difference from primary TKA (N=6); A denotes significant
difference from aseptic TKR (N=5); S denotes significant difference from septic TKR (N=6); all
symbols denote significance at the p<0.05 level.
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CYTOKINE CONCENTRATIONS AT INDIVIDUAL LOCATION- IMPLANTRELATED CYTOKINES
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Figure A. 2. Cytokine profiles in localized tissues in implant-related inflammation. Average
cytokine concentration at individual tissue locations are shown for all groups. Two-way ANOVAs
with Bonferroni’s post-test were conducted to test for significant differences between groups at
each tissue depth (p<0.05). Significant differences between groups at a particular location are
marked as: P denotes significant difference from primary TKA (N=6); A denotes significant
difference from aseptic TKR (N=5); S denotes significant difference from septic TKR (N=6); all
symbols denote significance at the p<0.05 level.
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Figure A. 3. Cytokine calibration curves for human inflammatory cytokines. Calibration curves
for cytokines were calculated using a four-parameter logistic (4PL) model in Bio-Plex Manager
4.1.1. Five calibration standards were used for each cytokine, and averages of duplicates are shown
with error bars denoting 2 standard deviations from the mean. Each graph title additionally shows
a number that indicates the bead region for that target in the Bio-Plex system.
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APPENDIX B: CHAPTER 3 SUPPLEMENTARY FIGURES
Table B. 1. Cytokine concentrations for Sham, Implant Only, and Inf+Implant groups. Values are expressed as nanograms of cytokine
per gram of tissue; average values ± SEM are listed. Note: all cytokines had associated error, but error is rounded to two decimal places.
Significant comparisons (p<0.05) between locations for each cytokine within each group are denoted with letters; contralateral knee: A;
operative leg proximal: B; operative knee: C; operative leg distal: D. For ease of reader, the significant comparisons between locations
(p<0.05) are simply marked via superscript letters to denote which locations are different. All comparisons were done via two-way
ANOVA followed by Bonferroni’s post-test.

IL-1α
IL-1β
IL-4
IL-5
IL-6
IL-10
IL-12p70
IL-13
GM-CSF
IFN-
TNF-α

Contra
0.07±
0.03
0.02±
0.00
0.11±
0.05
0.57±
0.01
0.90±
0.38
0.18±
0.12
0.98±
0.27
0.81±
0.30
0.17±
0.06
0.49±
0.24
0.85±
0.36

Sham
Op Prox Op Knee
0.30±
0.22±
0.13
0.09
0.11±
0.18±
0.05
0.00
0.37±
0.07±
0.08
0.04
0.07±
0.45±
0.04
0.34
0.62±
0.29±
0.00
0.04
0.55±
0.41±
0.39
0.01
1.58±
1.58±
0.43
0.39
0.26±
0.39±
0.12
0.10
0.23±
0.32±
0.02
0.09
0.50±
0.92±
0.09
0.31
1.87±
1.53±
0.51
0.01

Op Dist
0.26±
0.03
0.20±
0.06
0.37±
0.12
0.14±
0.00
0.94±
0.31
0.19±
0.12
1.93±
0.51
0.35±
0.00
0.64±
0.15
0.76±
0.18
3.96±
0.85

Contra
0.50±
0.09C,D
0.52±
0.10C
1.35±
0.04C
1.77±
0.32C,D
1.82±
0.98
1.73±
0.45C,D
5.38±
0.95C,D
2.03±
0.74C
1.08±
0.29C
3.87±
0.78C
4.66±
1.16

Implant Only
Op Prox Op Knee
0.54±
2.07±
0.17C
0.23A,B
0.72±
6.19±
0.18C,D
0.98A,B
0.82±
6.93±
0.36C
2.0 A,B
1.78±
5.38±
0.34C,D
0.70A,B
1.20±
7.71±
0.00
1.27
1.37±
6.89±
0.32C,D
1.24A,B
5.60±
25.51±
1.25C,D
2.96A,B
1.32±
6.58±
0.27C,D
1.56A,B
0.52±
6.65±
0.22C
1.23A,B,D
6.40±
10.97±
2.74
3.04A
3.08±
11.11±
0.70C
3.03B
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Op Dist
1.58±
0.27A
1.77±
0.21B
3.77±
1.75
4.93±
0.89A,B
7.90±
2.81
5.71±
1.35A,B
17.37±
4.49A,B
4.89±
1.11B
2.56±
0.98C
9.14±
1.83
7.41±
2.3

Contra
0.26±
0.05C,D
0.80±
0.28C
1.56±
0.58C
1.13±
0.29C
1.17±
0.16C
1.17±
0.04C
5.58±
0.62C
1.50±
0.28C
1.09±
0.26C
2.84±
0.23C
5.78±
2.56

Inf+Implant
Op Prox Op Knee
0.77±
2.09±
0.30D
0.36A,B
1.09±
10.08±
0.53C,D
0.10A,B
0.79±
13.15±
0.68C,D
1.98A,B
1.62±
5.79±
1.07C
0.70A,B,D
0.73±
17.27±
0.20C
6.70A,B,D
1.33±
6.43±
0.66C
0.07A,B,D
3.93±
18.14±
2.81C
5.08A,B
1.22±
6.20±
0.30C
0.95A,B,C
0.86±
5.85±
0.66C
0.47A,B,D
2.83±
12.57±
1.78D
3.13A
4.97±
9.79±
4.21
3.35

Op Dist
2.54±
1.26A,B
2.03±
0.33B
1.69±
1.64B
1.54±
0.35C
4.15±
2.65C
1.30±
0.80C
6.98±
1.38
1.47±
0.03C
0.90±
0.64C
5.04±
1.73B
6.02±
2.42

X-RAY IMAGES OF RODENTS AT 21 DAYS POST-SURGERY
Methods
Grading and Analysis of X-Rays
X-rays were taken on the day of operation as well as 21 days post-operation to compare joint
conditions. X-rays at each time point were graded using methods established by Aktekin, et al. to
evaluate the following parameters: periosteal reaction, diaphyseal widening, osteolysis, bone
formation, sequestrum, joint effusion, and swelling. Results for each of the three groups: Sham,
Implant Only, and Inf+Implant are displayed in Table S2. Representative x-ray images for each
group are displayed, labeled with group. X-rays are shown at 21 days post-operation, and a red
arrow points to the operative right knee joint. For some animals, staples can be seen on the right
hind limb. For Implant Only and Inf+Implant groups, K-wire implant is denoted at the red arrow.
X-Ray Analysis, Grading, and Results
Table B. 2. X-Ray Grading Scores for Sham (N=6), Implant Only (N=6), and Inf+Implant (N=6)
Groups at Post-Operative Day 0 (POD-0) and POD-21. X-rays were graded according to methods
established by Aktekin, et al.

Periosteal reaction
Diaphyseal widening
Osteolysis
Bone formation
Sequestrum
Joint effusion
Swelling

SHAM
POD 0
POD 21

IMPLANT ONLY
POD 0
POD 21

0.04167
0
0.08333
0
0
0
0

0.04167
0
0.04167
0
0
0
0

0.08333
0
0.08333
0
0
0
0
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0.08333
0.125
0.20833
0.04167
0
0
0

INF+IMPLANT
POD 0
POD 21
0
0
0
0
0
0
0

1.08333
0.875
1.20833
0.75
0.16667
0.04167
0

X-Ray Images of Sham, Implant Only, and Inf+Implant Groups
Sham Group X-rays at 21-day Time Point

Figure B. 1. X-ray images of Sham group rats at 21 days post-surgery. Radiographs are shown of
animals in the sham group. In some animals, staples can be seen. Red arrows indicate operative
knee.

Implant Only Group X-rays at 21-day Time Point

Figure B. 2. X-ray images of Impant Only group rats at 21 days post-surgery. Radiographs are
shown of animals in the Implant Only group. In some animals, staples can be seen. Red arrows
indicate operative knee.
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Inf+Implant Only Group X-rays at 21-day Time Point

Figure B. 3. X-ray images of Inf+Impant group rats at 21 days post-surgery. Radiographs are
shown of animals in the Inf+Implant group. In some animals, staples can be seen. Red arrows
indicate operative knee.
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CYTOKINE CONCENTRATIONS IN SERUM OF RODENTS AT 21 DAYS POSTOPERATION
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Figure B. 4. Cytokine profiles in localized tissues in infection-specific inflammation. Average
cytokine concentration in the serum of rats at the 21 day time point are shown for Sham, Implant
Only, and Inf+Implant groups. Two-way ANOVAs with Bonferroni’s post-test were conducted to
test for significant differences between groups, but no significant differences were observed at
p<0.05.
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CYTOKINE CALIBRATION CURVES
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Figure B. 5. Cytokine calibration curves for rodent inflammatory cytokines. Calibration curves
for cytokines were calculated using a four-parameter logistic (4PL) model in Bio-Plex Manager
4.1.1. Five calibration standards were used for each cytokine, and averages of duplicates are shown
with error bars denoting 2 standard deviations from the mean. Each graph title additionally shows
a number that indicates the bead region for that target in the Bio-Plex system.
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